Check the appropriate box below if the Form 8-K is intended to
simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. ¨
The Promissory Note was issued by P3 LLC to VBC
on December 13, 2022, and provides for funding of up to $40.0 million (the “Promissory Note”), available for draw by
P3 LLC in three tranches, as follows: (i) a first tranche of $15.0 million available to P3 LLC upon the Effective Date, (ii) a
second tranche of up to $15.0 million available at the Company’s sole option in a single draw, on or prior to January 5,
2023, and (iii) a third tranche of up to $10.0 million available at P3 LLC’s sole option
in a single draw, after January 5, 2023 and on or prior to February 3, 2023. The maturity date of the Promissory Note is May 19,
2026. Interest is payable at 14.0 % per annum on a quarterly cycle (in arrears) beginning March 31, 2023. P3 LLC may elect to pay
interest 6.0% in kind and 8.0% in cash, but if the terms of the Subordination Agreement (as defined below) do not permit P3 LLC to pay
interest in cash, interest will be paid entirely in-kind. The Promissory Note may be prepaid, at the Company’s option, either in
whole or in part, without penalty or premium, at any time and from time to time, subject to the payment of the back-end fee described
below; provided that prepayments must be in increments of at least $2.0 million. The Promissory Note provides for mandatory prepayments
with the proceeds of certain asset sales, and the Lender has the right to demand payment in full upon (i) a change of control of
the Company and (ii) certain qualified financings (as defined in the Promissory Note).
The Promissory Note restricts P3 LLC’s ability
and the ability of its subsidiaries to, among other things, incur indebtedness and liens, and make investments and restricted payments.
The maturity date may be accelerated as a remedy under the certain default provisions in the agreement, or in the event a mandatory prepayment
event occurs.
Pursuant to the Promissory Note, P3 LLC will pay
VBC an up-front fee of 1.5% at the time of each draw under the Promissory Note, In addition, P3 LLC will pay VBC a back-end fee at the
time the Promissory Note as follows: (i) if paid prior to February 28, 2023, 2.25%; (ii) if paid from March 1, 2023
through June 30, 2023, 4.5%; (iii) if paid from July 1, 2023 through December 31, 2021, 6.75% and (iv) if paid
on January 1, 2024 or later, 9.0%.
P3 LLC intends to use the proceeds of the Promissory
Note to fund the Company’s ongoing working capital requirements.
In connection with the Promissory Note, on December 13,
2022, P3 LLC and VBC entered into a Warrant (the “Warrant Agreement”). Pursuant to the Warrant Agreement, P3 LLC issued warrants
to purchase 429,180 shares of Class A Common Stock, par value $0.0001 per share, of the Company (the “Common Stock”),
at an exercise price of $4.26 per share (the “Warrants”) to VBC. The number of shares of Common Stock for which the Warrant
is exercisable and the exercise price may be adjusted upon any event involving subdivisions, combinations, distributions, recapitalizations
and like transactions. Pursuant to the Warrant Agreement, the Warrants and the right to purchase securities upon the exercise of the Warrants
will terminate upon the earliest to occur of the following: (a) December 13, 2027; and (b) the consummation of (i) a
sale, conveyance, disposal, or encumbrance of all or substantially all of the Company’s or P3 LLC’s
property or business or the Company’s or P3 LLC’s merger into or consolidation with any other corporation (other
than a wholly owned subsidiary corporation) or (ii) any other transaction or series of related transactions in which more than fifty
percent (50%) of the voting power of the Company or P3 LLC is disposed of.
In connection with the transactions described above,
P3 LLC entered into a subordination agreement, dated as of December 13, 2022 (the “Subordination Agreement”), by and
among the Company, CRG Services LLC, as administrative agent under the Company’s existing term loan facility (the “Term Loan
Facility”) and VBC. Pursuant to the Subordination Agreement, VBC agreed to subordinate its right of payment under the Promissory
Note to the right of payment and security interests of the lenders under the Term Loan Facility. The terms of the Subordination Agreement
will effectively require P3 LLC to pay all interest under the Promissory Note in-kind.
In connection with the transactions described above,
P3 LLC entered into an amendment to that certain Term Loan Agreement, dated as of December 3, 2021, by among P3 LLC, as borrower,
the subsidiary guarantors party thereto, the lenders from time to time party thereto and CRG Servicing LLC, as administrative agent and
collateral agent. The amendment permits the issuance of the Promissory Note and the entry into the Subordination Agreement.
The foregoing descriptions of the Promissory Note,
the Warrant Agreement, the Subordination Agreement and the Amendment to Term Loan Agreement do not purport to be complete and is qualified
in its entirely by the terms of the Promissory Note, the Warrant Agreement, the Subordination Agreement and the Amendment to the Term
Loan Agreement, copies of which are filed herewith as Exhibit 10.1, 10.2, 10.3 and 10.4, respectively, and are incorporated herein
by reference.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
P3 Health Partners Inc. |
|
|
|
|
Date: |
December 13, 2022 |
By: |
/s/ Jessica Puathasnanon |
|
|
|
Jessica Puathasnanon
Chief Legal Officer |
Exhibit 10.1
THIS Unsecured
Promissory Note (AS AMENDED, RESTATED OR OTHERWISE MODIFIED FROM TIME TO TIME, this “NOTE”) AND ANY SECURITIES
WHICH MAY BE ISSUED BY THE COMPANY (AS DEFINED BELOW) UNDER ITS TERMS HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933,
AS AMENDED (THE “ACT”), OR THE SECURITIES LAWS OF ANY STATE, AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH
A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH SALE OR DISTRIBUTION MAY BE EFFECTED WITHOUT AN EFFECTIVE
REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT
REQUIRED UNDER THE ACT.
THE INDEBTEDNESS
REPRESENTED BY THIS NOTE IS EXPRESSLY SUBORDINATED TO THE PAYMENT OF THE “SENIOR Debt” as defined IN that certain Subordination
Agreement dated as of december 13, 2022 (as amended from time to time, The “Subordination Agreement”) entered
into between Holder and CRG Servicing LLC (TOGETHER WITH ITS SUCCESSORS AND ASSIGNS, “CRG”), AS MORE PARTICULARLY
SET FORTH IN THE SUBORDINATION AGREEMENT.
THE FOLLOWING
INFORMATION IS SUPPLIED SOLELY FOR U.S. FEDERAL INCOME TAX PURPOSES. THIS NOTE WAS ISSUED WITH "ORIGINAL ISSUE DISCOUNT" (“OID”)
WITHIN THE MEANING OF SECTION 1273 OF THE INTERNAL REVENUE CODE OF 1986, AS AMENDED (THE “CODE”), AND THIS
LEGEND IS REQUIRED BY SECTION 1275(c) OF THE CODE. HOLDER MAY OBTAIN INFORMATION REGARDING THE AMOUNT OF ANY OID, THE ISSUE
PRICE, THE ISSUE DATE, AND THE YIELD TO MATURITY RELATING TO THE NOTES BY CONTACTING ChIEF FINANCIAL OFFICER AT 2370 Corporate Circle,
Suite 300, Henderson, NV 89074.
UNSECURED PROMISSORY NOTE
$40,000,000.00 | December 13, 2022 |
FOR VALUE RECEIVED, P3
Health Group, LLC, a Delaware limited liability company (the “Company”), hereby promises to pay to VBC
Growth SPV LLC, a Delaware limited liability company (“Holder”), the principal sum of up to Forty Million and
00/100 Dollars ($40,000,000.00) (“Maximum Loan Amount”), at the place and in the manner hereinafter provided,
together with interest thereon at the rate or rates, and on the terms, described below, and any and all other amounts which may be due
and payable hereunder from time to time.
1. Advances
of the Loan.
(a) Subject
to the terms and conditions hereof, Holder hereby extends to the Company a line of credit facility pursuant to which Holder will
make loans to the Company upon the Company’s request subject to this Section 1(a) and Section 1(b) from
time to time until the Maturity Date in an amount not exceeding, in the aggregate, the Maximum Loan Amount (each amount advanced
by Holder to the Company hereunder, a “Loan”, and collectively, the “Loans”).
The Company may not reborrow any amounts repaid by Company under the Loans. The Loans will be available for draw by the Company as follows:
| i. | A first tranche of $15,000,000 (the “First Tranche”) available to the Company
upon the date hereof. |
| ii. | A second tranche of up to $15,000,000 (the “Second Tranche”) available at the
Company’s sole option in a single draw, on or prior to January 5, 2023. |
| iii. | A third tranche of up to $10,000,000 (the “Third Tranche”) available at the
Company’s sole option in a single draw, after January 5, 2023 and on or prior to February 3, 2023. |
(b) Subject
to Section 1(a), the Holder agrees to fund draws of the Loans to the Company promptly upon written request from the Company
to the Holder, but in any event, (1) with respect First Tranche, on the date of Holder’s receipt of a written draw request
from the Company and (2) with respect to the Second Tranche and the Third Tranche, within five (5) Business Days of Holder’s
receipt of a written draw request from the Company. All draw requests shall include a certification, explicitly or by implication evidenced
by the delivery of the request, from the Company’s representative executing the written draw request that (i) no Event of Default
has occurred and is continuing hereunder; and (ii) such representative has all necessary authorizations to submit the request on
behalf of the Company, and Holder shall be entitled to rely on such certification.
(c) The
Holder is hereby authorized by the Company to record on a schedule annexed to this Note (or on a supplemental schedule) the amounts
owing with respect to the Loans, and the payment thereof. Notwithstanding the foregoing, however, Holder’s failure to make
any such recording or notation shall not affect in any manner the rights of the Holder or any obligations of the Company hereunder.
2. Maturity.
Unless accelerated or otherwise paid or payable sooner in accordance with the terms set forth herein, this Note will automatically mature
and be due and payable on May 19, 2026 (the “Maturity Date”).
3. Interest.
(a) Interest
Generally. Subject to Section 3(d) and the Subordination Agreement, the Company agrees to pay to the Holder interest
on the unpaid principal amount of the Loans (including, for the avoidance of doubt, PIK Loans) and the amount of all other outstanding
Obligations (other than Warrant Obligations), in the case of the Loans, for the period from the applicable borrowing date and,
in the case of any other Obligation (other than Warrant Obligations), from the date such other Obligation (other than Warrant
Obligations) is due and payable, in each case, to and including the date on which such Loan or Obligation is paid in full, at a
rate per annum equal to fourteen percent (14%).
(b) Default
Interest. Notwithstanding the foregoing, automatically upon the occurrence and during the continuance of any Event of Default
under Section 8, the interest payable pursuant to Section 3(a) shall increase automatically by four
percent (4.00%) per annum (such aggregate increased rate, the “Default Rate”). Notwithstanding any other
provision herein (including Section 3(d)) but subject to the terms of the Subordination Agreement, if interest is required
to be paid at the Default Rate, it shall be paid entirely in cash.
(c) Interest
Payment Dates. Subject to Section 3(d) and the Subordination Agreement, accrued interest on the Loans shall be payable
in arrears on each Payment Date with respect to the most recently completed Interest Period in cash, and upon the payment or prepayment
of the Loans (on the principal amount being so paid or prepaid); provided, that, subject to the terms of the Subordination
Agreement, interest payable at the Default Rate shall be payable from time to time on demand.
(d) Paid
In-Kind Interest. Notwithstanding Section 3(a), so long as no Event of Default has occurred and is continuing,
the Company may elect at any time to pay interest on the outstanding principal amount of the Loans as follows: (i) eight percent
(8.00%) per annum interest payable in cash and (ii) six percent (6.00%) per annum interest payable as compounded interest,
added to the aggregate principal amount of the Loans for all purposes under this Note on such Payment Date (the amount of any such
compounded interest being a “PIK Loan”); provided that payment of interest in cash will be required only to
the extent permitted pursuant to the terms of the Subordination Agreement, and if payment in cash not so permitted, all cash interest
shall accrue as a PIK Loan. The principal amount of each PIK Loan under this Section 3(d) shall accrue interest
in accordance with the provisions of this Note applicable to the Loans. The PIK Loans shall not reduce the availability of the First Tranche,
Second Tranche or Third Tranche.
(e) Computations.
All computations of interest and fees hereunder shall be computed on the basis of a year of 360 days and actual days elapsed during the
period for which payable.
4. Payments.
(a) Repayment.
Unless otherwise accelerated in accordance with the terms hereof, no scheduled payments of principal of the Loans shall be due
prior to the Maturity Date. The Company agrees to repay to the Holder the outstanding principal amount of the Loans (including,
for the avoidance of doubt, PIK Loans), together with all other outstanding Obligations (other than Warrant Obligations and contingent
indemnification obligations for which no claim has been made), on the Maturity Date (subject to the terms and conditions
of the Subordination Agreement).
(b) Application.
Any optional or mandatory prepayment of the Loans shall be applied to the Loans (and PIK Loans in respect thereof) in the inverse
order in which such Loans were made.
(c) Prepayments.
This Note may be prepaid, either in whole or in part, without penalty or premium, at any time and from time to time; provided that
repayments of the obligations hereunder by the Company must be in increments equal to at least 5% of Maximum Loan Amount.
(d) Mandatory
Prepayments.
| i. | Asset Sales. In the event of any contemplated Asset Sale or Involuntary Disposition, as
applicable, or series of related Asset Sales or Involuntary Dispositions, as applicable, yielding Asset Sale Net Proceeds in excess
of three million Dollars ($3,000,000) in the aggregate for all Asset Sales and Involuntary Dispositions (and series thereof) during
the term of this Note, the Company shall provide at least three (3) Business Days’ prior written notice of such Asset
Sale, Involuntary Disposition or series thereof, as applicable, to the Holder and shall, not later than the date that is
three (3) Business Days after the date of such Asset Sale, Involuntary Disposition or series thereof, as applicable,
in each case to the extent permitted pursuant to the Subordination Agreement: (x) if the assets subject to such Asset Sale, Involuntary
Disposition or series thereof represent substantially all of the assets or revenues of the Company and its subsidiaries, on a consolidated
basis, or represent any specific line of business which either on its own or together with other lines of business sold or otherwise
disposed of over the term of this Note account for revenue generated by such lines of business exceeding fifteen percent (15%)
of the revenue of the Company and its subsidiaries, on a consolidated basis, in the immediately preceding year, prepay the aggregate
Obligations (other than Warrant Obligations) outstanding on the date of such Asset Sale, Involuntary Disposition or series
thereof, and (y) in the case of all other Asset Sales, Involuntary Dispositions and series thereof not described
in the foregoing clause (x), prepay the Loans in an amount equal to the entire amount of the Asset Sale Net Proceeds of such Asset
Sale, Involuntary Disposition or series thereof, plus any accrued but unpaid interest and any fees (including the Back-End
Facility Fee, if applicable) then due and owing with respect to the principal amount of the Loans being prepaid, credited in accordance
with Section 4(b) above. |
| ii. | Change of Control; Qualified Financing.
In the event of a Change of Control or a Qualified Financing, the Company shall immediately
provide notice of such Change of Control or Qualified Financing to the Holder and,
subject to the terms of the Subordination Agreement, if within ten (10) days of receipt
of such notice, the Holder advises the Company that the Holder requires a prepayment
pursuant to this Section 4(d)(ii), the Company shall prepay the aggregate Obligations
(other than Warrant Obligations) outstanding on the date of such Change of
Control or Qualified Financing and pay any fees payable (including the Back-End Facility
Fee). |
5. Fees.
(a) On
the date hereof, the Company shall pay to the Holder an aggregate upfront financing fee in an amount equal to one and one half percent
(1.50%) of the First Tranche, which fee is deemed fully earned on the date hereof (the “Closing Date
Financing Fee”).
(b) On
the date of any borrowing after the date hereof, the Company shall pay to the Holder an aggregate upfront financing fee in an amount equal
to one and one half percent (1.50%) of the principal amount of such borrowing, which fee is deemed fully earned on the date
of such borrowing (each such upfront financing fee, together with the Closing Date Financing Fee, a “Financing Fee”
and collectively, the “Financing Fees”). Each Financing Fee shall be paid by netting it out of the amount
of the applicable borrowing.
(c) On
the earlier of (a) the Maturity Date and (b) the date the Loans become due and payable in full for any other reason (including,
without limitation, the prepayment by the Company, the requirement of a mandatory prepayment under Section 4(d) above
or an acceleration under Section 7 below) (the “Loan Repayment Date”), the Company shall pay to
the Holder, to the extent permitted pursuant to the Subordination Agreement, an aggregate fee in an amount equal to: (1) if the Loan
Repayment Date is on or prior to February 28, 2023, 2.25% of the aggregate principal amount of the Loans (including, for the
avoidance of doubt, the aggregate principal amount of all PIK Loans issued) advanced to the Company on or prior to such date, (2) if
the Loan Repayment Date is after February 28, 2023 but on or prior to June 30, 2023, 4.5% of the aggregate principal
amount of the Loans (including, for the avoidance of doubt, the aggregate principal amount of all PIK Loans issued) advanced to
the Company on or prior to such date, (3) if the Loan Repayment Date is after June 30, 2023 but on or prior December 31,
2023, 6.75% of the aggregate principal amount of the Loans (including, for the avoidance of doubt, the aggregate principal
amount of all PIK Loans issued) advanced to the Company on or prior to such date, or (4) if the Loan Repayment Date is after December 31,
2023, 9.00% of the aggregate principal amount of the Loans (including, for the avoidance of doubt, the aggregate principal
amount of all PIK Loans issued) advanced to the Company on or prior to such date (such applicable fee, the “Back-End
Facility Fee”), less any partial payment of the Back-End Facility Fee already paid by the Company prior to such date,
in connection with the partial prepayment of the Loans, as described in the next sentence. Notwithstanding the foregoing, if the
Company makes a partial prepayment of the Loans through the exercise of an optional prepayment under Section 4(c) or
a partial mandatory prepayment pursuant to Section 4(d)(i), the Company shall pay, to the extent permitted pursuant to the
Subordination Agreement, on such date of prepayment, to the Holder for the account of the Holder, an aggregate fee in an amount
equal to Back-End Facility Fee applicable to the principal amount of such payment (it being understood and agreed that any fee
paid pursuant to this sentence shall constitute a partial payment of the Back-End Facility Fee (as described in the immediately
preceding sentence)).
(d) All
amounts payable by the Company hereunder, other than interest payable in kind, shall be paid by the Company unconditionally in full
without set-off (except as otherwise expressly provided herein) or counterclaim or other defense, in U.S. Dollars and in same day
or immediately available funds, to such account as the Holder shall designate. The fees payable hereunder shall be fully earned
upon becoming due and payable, shall be non-refundable for any reason whatsoever and shall be in addition to any other fee,
cost or expense payable pursuant to the Loan Documents.
6. Covenants.
The Company covenants and agrees with the Holder that, until all Obligations (other than Warrant Obligations and contingent indemnification
obligations for which no claim has been made) have been paid in full in cash:
(a) The
Company shall deliver to the Holder, concurrently with delivery to CRG, each of the items set forth in Section 8.01 of the Senior
Loan Agreement (as in effect on the date hereof).
(b) To
the extent the Company performs a monthly operating review, the Company shall deliver to the Holder, promptly following the completion
thereof, a reasonably detailed report of the results thereof.
(c) The
Company shall deliver to the Holder, on a bi-weekly basis, cash forecasts for the succeeding two-month period in the form provided in
the Forecast (as defined below).
(d) The
Company shall deliver to the Holder, concurrently with delivery to CRG, the notices set forth in Section 8.02 of the Senior Loan
Agreement (as in effect on the date hereof).
(e) The
Company shall, and shall cause each of its subsidiaries to, permit any representatives designated by the Holder, upon reasonable prior
notice, to visit and inspect its properties, to examine and make extracts from its books and records, to inspect its facilities and to
discuss its affairs, finances and condition with its officers and, in the presence of an officer of the Company, its independent accountants,
all at such reasonable times and intervals (but not more often than once per calendar quarter in the aggregate unless an Event of Default
has occurred and is continuing) as the Holder may request.
(f) The
Company shall not, and shall not permit any of its subsidiaries to, create, incur, assume or permit to exist any Indebtedness (as defined
in the Senior Loan Agreement (as in effect on the date hereof)), in any form, whether directly or indirectly, except (i) the Obligations,
(ii) the obligations under the Senior Loan Agreement, (iii) the Intermountain Obligations, (iv) Indebtedness that is subordinate
to the Obligations pursuant to the terms of a binding agreement between the lender thereof and the Holder, (v) Indebtedness outstanding
on the date of this Note (and any refinancing thereof in a manner that does not increase the principal amount thereof) and (v) any
other Indebtedness permitted by Section 9.01 of the Senior Loan Agreement (as in effect on the date hereof), excluding Sections 9.01(n),
(o) and (s) of the Senior Loan Agreement (as in effect on the date hereof) unless such Indebtedness is expressly subordinated
to the Obligations on terms reasonably satisfactory to the Holder.
(g) The
Company shall not, and shall not permit any of its subsidiaries to, create, incur, assume or permit to exist any Lien on any property
or asset now owned or hereafter acquired by it, or assign or sell any income or revenues (including accounts receivable) or rights in
respect of any thereof, except for (i) the Liens granted to CRG in connection with the Senior Loan Agreement, (ii) Liens outstanding
on the date of this Note (and any refinancing thereof in a manner that does not increase the obligations secured thereby) and (iii) any
other Lien permitted by Section 9.02 of the Senior Loan Agreement (as in effect on the date hereof), excluding Sections 9.02(c) and
(r) of the Senior Loan Agreement (as in effect on the date hereof).
(h) The
Company shall not, and shall not permit any of its subsidiaries to, declare or make, or agree to pay or make, directly or indirectly,
any Investments or Restricted Payments (each as defined in the Senior Loan Agreement (as in effect on the date hereof)), other than any
such Investments permitted by Section 9.05 of the Senior Loan Agreement (as in effect on the date hereof) and Restricted Payments
permitted by Section 9.06 of the Senior Loan Agreement (as in effect on the date hereof).
(i) During
the period covered by the Forecast, the Company shall not, and shall not permit any of its subsidiaries to, declare or make, or agree
to pay or make, directly or indirectly, any material disbursements or other payments outside the ordinary course of business that are
not contemplated by the Forecast. “Forecast” means that certain cash flow update and projection dated December 9, 2022
attached hereto as Exhibit A, and as shall be updated to include projections for the month of February.
7. Events
of Default. In the case of the happening of any of the following events, if any (each, an “Event of Default”):
(a) the
Company shall fail to pay any Obligation hereunder, when and as the same shall become due and payable, whether at the due date thereof
or by acceleration thereof or otherwise; or
(b) an
involuntary proceeding shall be commenced or an involuntary petition shall be filed seeking (i) liquidation, reorganization or other
relief in respect of the Company or its debts, or of a substantial part of its assets, under any federal, state or foreign bankruptcy,
insolvency, receivership or similar law now or hereafter in effect or (ii) the appointment of a receiver, trustee, custodian, sequestrator,
conservator or similar official for the Company or for a substantial part of its assets, and, in the case of each of the foregoing, such
proceeding or appointment continues undismissed, or unstayed and in effect, for a period of forty-five (45) days after the institution
thereof; provided, that, if an order, decree or judgment is granted or entered (whether or not entered or subject to appeal) against Company
in the interim, such grace period will cease to apply; provided further, that, if the Company files an answer admitting the material allegations
of a petition filed against it in any such proceeding, such grace period will cease to apply;
(c) the
Company shall (i) voluntarily commence any proceeding or file any petition seeking liquidation, reorganization or other relief under
any federal, state or foreign bankruptcy, insolvency, receivership or similar law now or hereafter in effect, (ii) consent to the
institution of, or fail to contest in a timely and appropriate manner, any proceeding or petition described in clause (b) of this
Section 7, (iii) apply for or consent to the appointment of a receiver, trustee, custodian, sequestrator, conservator or similar
official for the Company or for a substantial part of its assets, (iv) file an answer admitting the allegations of a petition filed
against it in any such proceeding, (v) admit in writing its inability to pay its debts as they come due or make a general assignment
for the benefit of creditors or (vi) take any action for the purpose of effecting any of the foregoing; or
(d) the
failure by the Company to observe any of the covenants set forth in Section 6(f), (g) or (h); or
(e) the
failure by the Company to observe any other covenant set forth herein and such failure shall continue unremedied for a period of thirty
(30) days after the earlier of the date on which (i) an officer of the Company obtains knowledge of such failure and (ii) written
notice of such failure shall have been given to the Company by Lender; or
(f) the
occurrence of any “event of default” or similar event under the Senior Loan Agreement (as in effect on the date hereof) or
Intermountain Note; or
(g) any
Material Adverse Change (as defined in the Senior Loan Agreement (as in effect on the date hereof)) shall occur; or
(h) one
or more judgments or settlements for the payment of money in an aggregate amount in excess of two million five hundred thousand Dollars
($2,500,000) (or the equivalent amount in other currencies) shall be rendered against or entered into by the Company, any of its subsidiaries
or any combination thereof and (i) the same shall remain undismissed, unsatisfied or undischarged for a period of forty-five (45)
consecutive days during which execution shall not be effectively stayed or (ii) any action shall be legally taken by a judgment or
settlement creditor to attach or levy upon any assets of the Company or any of its subsidiaries to enforce any such judgment or settlement;
then, and in every such
event (other than an event described in clause (b) or (c) of this Section), and at any time thereafter during the
continuance of such event, the Holder may, by notice to the Company, in addition to, and not in limitation of, any other rights to
which Holder is or may be entitled, declare this Note to be due and payable in whole (or in part, in which case any principal not so
declared to be due and payable may thereafter be declared to be due and payable), and thereupon the principal of this Note so
declared to be due and payable, together with accrued interest thereon and all fees and other obligations of the Company accrued
hereunder, shall become due and payable immediately, without presentment, demand, protest or other notice of any kind, all of which
are hereby waived by the Company; and in the case of any event described in clause (b) or (c) of this Section, this Note
shall automatically be due and payable in whole, and thereupon the entire principal of this Note, together with accrued interest
thereon and all fees and other obligations of the Company accrued hereunder, shall become due and payable immediately, without
presentment, demand, protest or other notice of any kind, all of which are hereby waived by the Company. Holder’s delay or
failure to exercise any right shall not be deemed a waiver of such right or any other right available to Holder.
THE COMPANY HEREBY WAIVES PRESENTMENT, DEMAND
FOR PAYMENT, NOTICE OF DISHONOR, NOTICE OF PROTEST, PROTEST AND ANY AND ALL OTHER NOTICES OR DEMANDS IN CONNECTION WITH THE DELIVERY,
ACCEPTANCE, PERFORMANCE, DEFAULT, OR ENFORCEMENT OF THIS NOTE. No failure to accelerate or demand payment of the indebtedness evidenced
hereby by reason of an Event of Default hereunder, and no indulgence that may be granted from time to time, shall be construed (i) as
a novation of this Note or as a reinstatement of the indebtedness evidenced hereby or as a waiver of such right of acceleration or of
the right of Holder thereafter to make demand for payment or otherwise to insist upon strict compliance with the terms of this Note, or
(ii) to prevent the exercise of such right of acceleration, or to demand payment, or any other right granted hereunder or under applicable
law; and the Company hereby expressly waives the benefit of any statute or rule of law or equity now provided or that may hereafter
be provided that would produce a result contrary to or in conflict with the foregoing. No extension of the time for the payment of this
Note shall operate to release, discharge, modify, change or affect the original liability of the Company under this Note, either in whole
or in part, unless Holder agrees otherwise in writing.
8. Warrants.
Concurrently herewith, and in consideration of the Holder’s obligations hereunder, the Company and the Holder are entering into
that certain Class A Common Stock Purchase Warrant dated as of the date hereof (the “Warrant Agreement”).
9. Subordination.
Notwithstanding anything in this Note to the contrary, the indebtedness, interest thereon and all other obligations of the Company
hereunder are subordinated in right of payment and the exercise of any right or remedy hereunder is subordinated, in each case,
to the payment of all obligations of the Company to CRG and the other Secured Parties (as defined in the Senior Loan Agreement (as in
effect on the date hereof)) pursuant to the Senior Loan Agreement and the other Loan Documents (as defined in the Senior Loan Agreement
(as in effect on the date hereof)) pursuant to and in accordance with the terms of the Subordination Agreement.
10. Expenses;
Indemnification, Etc.
(a) Expenses.
The Company agrees to pay or reimburse Holder for all of its reasonable out-of-pocket costs and expenses (including the reasonable fees
and expenses of Locke Lord LLP, as primary counsel to Holder) in connection with (i) the negotiation, preparation, execution
and delivery of this Note and the other Loan Documents and the making of the Loans, (ii) post-closing costs and (iii) the
negotiation or preparation of any modification, supplement or waiver of any of the terms of this Note or any of the other Loan
Documents (whether or not consummated), and (iv) any enforcement or collection proceedings resulting from the occurrence
of an Event of Default.
(b) Indemnification.
The Company hereby indemnifies Holder, its affiliates, and their respective directors, officers, employees, attorneys, agents,
advisors and controlling parties (each, an “Indemnified Party”) from and against, and agrees to hold
them harmless against, any and all Claims and Losses of any kind that may be incurred by or asserted or awarded against any Indemnified
Party, in each case arising out of or in connection with or relating to this Note or any of the other Loan Documents or
the transactions contemplated hereby or thereby or any use made or proposed to be made with the proceeds of the Loans, and any
claim, investigation, litigation or proceeding or the preparation of any defense with respect thereto arising out of or in connection
with or relating to any of the foregoing, whether or not any Indemnified Party is a party to an actual or prospective claim,
litigation, investigation or proceeding relating to any of the foregoing, whether based in contract, tort or any other theory,
and whether or not such investigation, litigation or proceeding is brought by the Company, any of its shareholders or creditors,
and whether or not the other transactions contemplated by this Note are consummated, IN ALL CASES, WHETHER OR NOT CAUSED BY OR ARISING, IN
WHOLE OR IN PART, OUT OF THE COMPARATIVE, CONTRIBUTORY OR SOLE NEGLIGENCE OF THE INDEMNIFIED PARTY, except to the extent such Claim
or Loss (x) is found in a final, non-appealable judgment by a court of competent jurisdiction to have resulted from
such Indemnified Party’s gross negligence or willful misconduct, (y) results from a claim brought by the Company or
any subsidiary against an Indemnified Party for material breach in bad faith of such Indemnified Party’s obligations hereunder
or under any other Loan Document, if the Company or such subsidiary has obtained a final and non-appealable judgment in its favor
on such claim as determined by a court of competent jurisdiction or (z) arises solely from a dispute between or among
Indemnified Parties and does not relate to (i) any action of any such Indemnified Party in its capacity as Holder or (ii) any
act or omission on the part of the Company and its subsidiaries, in each case, as determined by a court of competent jurisdiction
in a final, non-appealable judgment. The Company shall not assert any claim against any Indemnified Party, on any theory
of liability, for consequential, indirect, special or punitive damages arising out of or otherwise relating to this Note or any
of the other Loan Documents or any of the transactions contemplated hereby or thereby or the actual or proposed use of the
proceeds of the Loans
(c) This
Section 10 shall not apply with respect to taxes other than any taxes that represent losses, claims, damages, etc. arising from
any non-tax claim..
11. Defined
Terms.
(a) “Asset
Sale” means any sale, lease, license, transfer, or otherwise disposition of any of the Company’s or its subsidiaries’
property (including accounts receivable and Equity Interests of subsidiaries) to any person in one transaction or series of transactions,
except:
| i. | transfers of cash in the ordinary course of its business for equivalent value; |
| ii. | sales of inventory in the ordinary course of its business on ordinary business terms; |
| iii. | development and other collaborative arrangements where such arrangements provide for the licenses or disclosure
of intellectual property rights in the ordinary course of business and consistent with general market practices where such license requires
periodic payments based on per unit sales of a product, service or procedure over a period of time; provided, that, each
such license does not effect a legal transfer of title to such intellectual property rights, that each such license must be a true license
as opposed to a license that is a sales transaction in substance and that each such license does not materially restrict the ability of
the Company or any of its subsidiaries to commercialize any material product of, or provide any material service or procedure by, the
Company or any of its subsidiaries; |
| iv. | licenses, sublicenses, leases or subleases granted to third parties in the ordinary course of business
(but limited, in the case of licenses of intellectual property, to non-exclusive licenses), in each case, not interfering with the business
of the Company and its subsidiaries; |
| v. | the sale or discount, in each case without recourse, of accounts receivable arising in the ordinary course
of business in connection with the collection or compromise thereof; |
| vi. | the lapse, abandonment, of other disposition of intellectual property that in the commercially reasonable
business judgment of the Company is not (i) necessary or material for the conduct of the businesses of the Company and its subsidiaries
or (ii) material to the value of the Company and its subsidiaries; and |
| vii. | dispositions, sales or other transfers among the Company and its subsidiaries. |
(b) “Asset
Sale Net Proceeds” means the aggregate amount of the cash proceeds received from any Asset Sale or Involuntary Disposition,
net of (a) any bona fide costs and expenses incurred in connection with such Asset Sale or Involuntary Disposition, as applicable,
(b) income, franchise, sales and other applicable taxes paid or required to be paid (as reasonably estimated in good faith by the
Company) as a result of such Asset Sale or Involuntary Disposition, as applicable, in respect of the taxable year such Asset Sale or Involuntary
Disposition, as applicable, is consummated, the computation of which shall, in each case take into account the actual reduction in tax
liability resulting from any available operating losses, net operating loss carryovers, tax credits, tax carry forwards or similar tax
attributes, or deductions and any tax sharing arrangements, (c) the amount of any reasonable reserve established in accordance with
GAAP against any adjustment to the sale price or any liabilities related to any of the assets sold (provided, that, to the
extent and at the time any such amounts are released from reserve, such amounts shall constitute Asset Sale Net Proceeds) and (d) amounts
required to be applied to the prepayment of the obligations under the Senior Loan Agreement.
(c) “Board”
means (a) with respect to a corporation, the board of directors of the corporation or any committee thereof to the extent duly authorized
to act on behalf of such board, (b) with respect to a partnership, the board of directors of the general partner of the partnership,
(c) with respect to a limited liability company, the managing member or members or any controlling committee of managing members
thereof or if not member-managed, the managers thereof, or any committee of managing members or managers thereof to the extent duly authorized
to act on behalf of such Persons, and (d) with respect to any other Person, the board or committee of such Person serving a similar
function.
(d) “Business
Day” means a day (other than a Saturday or Sunday) on which commercial banks are not authorized or required to close
in New York City.
(e) “Change
of Control” means (a) at any time and for any reason whatsoever, any “person” or “group” (within
the meaning of Sections 13(d) and 14(d) of the Securities Exchange Act of 1934 (the “Exchange Act”)),
other than any of the Holdings Permitted Holders, is or becomes the beneficial owner (as defined in Rule 13d-3 under the Exchange
Act, except that a person or group shall be deemed to have “beneficial ownership” of all securities that such person or group
has the right to acquire (such right, an “option right”), whether such right is exercisable immediately or only after the
passage of time), directly or indirectly, of thirty-five percent (35%) or more of the Equity Interests of Holdings entitled to vote for
members of the Board of Holdings on a fully diluted basis (and taking into account all such securities that such person or group has the
right to acquire pursuant to any option right), (b) at any time and for any reason whatsoever, the Permitted Holders shall cease
to own and control, directly or indirectly, beneficially and of record, Equity Interests representing more than fifty percent (50%) of
the aggregate ordinary voting power for the election of the Board of the Company represented by the issued and outstanding Equity Interests
of the Company on a fully-diluted basis, (c) at any time and for any reason whatsoever, Holdings shall cease to be the sole managing
member of the Company, (d) the occurrence of any “Change of Control” (or any equivalent term) under any the Senior Loan
Agreement (as in effect on the date hereof) or the Intermountain Note.
(f) “Claims”
means any claims, demands, complaints, grievances, actions, applications, suits, causes of action, orders, charges, indictments, prosecutions,
informations (brought by a public prosecutor without grand jury indictment) or other similar processes, assessments or reassessments.
(g) “Controlled
Investment Affiliate” means, as to any Person, any other Person which directly or indirectly is in control of, is controlled
by, or is under common control with such Person and is organized by such first Person (or any other Person controlling such first Person)
primarily for making equity investments in Company or any other portfolio companies in the ordinary course of business.
(h) “Equity
Interest” means, with respect to any person, any and all shares (including, for the avoidance of doubt, shares of
capital stock), interests, participations or other equivalents, including membership interests (however designated, whether voting
or nonvoting), of equity of such person, including, if such person is a partnership, partnership interests (whether general or
limited) and any other interest or participation that confers on a person the right to receive a share of the profits and losses of,
or distributions of property of, such partnership, but excluding debt securities convertible or exchangeable into such equity or
other interests described in this definition.
(i) “Holdings”
means P3 Health Partners Inc., a Delaware corporation.
(j) “Holdings
Permitted Holders” means Chicago Pacific Capital, L.P., Chicago Pacific Founders GP, L.P. and their respective Controlled
Investment Affiliates.
(k) “Interest
Period” means, with respect to each borrowing of a Loan, (i) initially, the period commencing on and including the
borrowing date thereof and ending on and excluding the next Payment Date, and, (ii) thereafter, each period beginning on and including
the last day of the immediately preceding Interest Period and ending on and excluding the earlier of (x) the next succeeding Payment
Date and (y) the Maturity Date; provided, that, the Interest Period ending on the Maturity Date shall include the Maturity
Date.
(l) “Intermountain
Obligations” means the Company’s obligations to IHC Health Services, Inc. pursuant to the terms of that certain
Repurchase Promissory Note, dated as of June 28, 2019, as amended, restated, supplemented or otherwise modified from time to time
(the “Intermountain Note”).
(m) “Involuntary
Disposition” means any loss of, damage to or destruction of, or any condemnation or other taking for public use of, any
property of the Company or any subsidiary of the Company.
(n) “Lien”
means any mortgage, lien, pledge, charge or other security interest, or any lease, title retention agreement, mortgage, restriction, easement,
right-of-way, option or adverse claim (of ownership or possession) or other encumbrance of any kind or character whatsoever or any preferential
arrangement that has the practical effect of creating a security interest.
(o) “Loan
Documents” means, collectively, this Note, the Warrant Agreement, the Warrant, the Subordination Agreement, and any other
present or future document, instrument, agreement or certificate executed by the Company and delivered to the Holder in connection with
or pursuant to this Note or the Loans, all as amended, restated, supplemented or otherwise modified.
(p) “Loss”
means judgments, debts, liabilities, expenses, costs, damages or losses, contingent or otherwise, whether liquidated or unliquidated,
matured or unmatured, disputed or undisputed, contractual, legal or equitable, including loss of value, professional fees, including fees
and disbursements of legal counsel on a full indemnity basis, and all costs incurred in investigating or pursuing any Claim or any proceeding
relating to any Claim.
(q) “Obligations”
means, with respect to the Company, all amounts, obligations, liabilities, covenants and duties of every type and description owing by
the Company to the Holder, any indemnitee hereunder or any participant, arising out of, under, or in connection with, any Loan Document,
whether direct or indirect (regardless of whether acquired by assignment), absolute or contingent, due or to become due, whether liquidated
or not, now existing or hereafter arising and however acquired, and whether or not evidenced by any instrument or for the payment of money,
including, without duplication, (a) all Loans, (b) all interest, whether or not accruing after the filing of any petition in
bankruptcy or after the commencement of any insolvency, reorganization or similar proceeding, and whether or not a claim for post-filing
or post-petition interest is allowed in any such proceeding, and (c) all other fees, expenses (including reasonable out-of-pocket
fees, charges and disbursements of counsel), interest, commissions, charges, costs, disbursements, indemnities and reimbursement of amounts
paid and other sums chargeable to the Company under any Loan Document.
(r) “Payment
Date” means (a) each March 31, June 30, September 30 and December 31 (commencing on the first such
date to occur at least thirty (30) days after the date hereof) and (b) the Maturity Date; provided, that, if any such
date shall occur on a day that is not a Business Day, the applicable Payment Date shall be the next preceding Business Day.
(s) “Permitted
Holders” means Chicago Pacific Capital, L.P., Chicago Pacific Founders GP, L.P., Holdings and their respective Controlled
Investment Affiliates.
(t) “Person”
means any individual, corporation, company, voluntary association, partnership, limited liability company, joint venture, trust, unincorporated
organization or Governmental Authority or other entity of whatever nature.
(u) “Qualified
Financing” means the Company obtaining in one transaction or a series of related transactions financing through the sale
of equity securities or debt securities, however structured, in an amount sufficient to permit the Company to repay in full all obligations
payable under the Senior Loan Agreement.
(v) “Senior
Loan Agreement” means that certain Term Loan Agreement dated as of November 19, 2020 by and among the Company, as borrower,
the subsidiary guarantors from time to time party thereto, CRG, as administrative agent and collateral agent, and the lenders from time
to time party thereto, as amended on November 16, 2021 and December 21, 2021 and as further amended, restated, supplemented
or otherwise modified from time to time.
(w) “Warrant”
has the meaning set forth in the Warrant Agreement.
(x) “Warrant
Obligations” means, with respect to the Company and Holdings, all Obligations arising out of, under or in connection with,
the Warrant.
12. Other
General Agreements.
(a) The
Company agrees that the Loan evidenced by this Note is an exempted transaction under the Truth In Lending Act, 15 U.S.C., Section 1601,
et seq.
(b) Time
is of the essence hereof. If any payment of principal or interest on this Note shall become due on a day that is not a Business Day, the
payment will be made on the next succeeding Business Day.
(c) This
Note is governed and controlled as to validity, enforcement, interpretation, construction, effect and in all other respects by the statutes,
laws and decisions of the State of Delaware (without giving effect to Delaware conflict of laws principles). This Note may not be changed
or amended orally but only by an instrument in writing signed by the party against whom enforcement of the change or amendment is sought.
(d) The
Company further agrees, in the event that this Note or any portion of the debt evidenced hereby is collected by law or through an attorney
at law, to pay all costs of collection, including, without limitation, reasonable attorneys’ fees and all other reasonable costs
of collection, which, if unpaid after Holder’s demand, shall be added to the principal balance of this Note and accrue interest
as provided herein.
(e) The
Company agrees that Holder may assign this Note, and all rights of Holder accruing hereunder, to an affiliate of Holder upon written notice
of assignment from Holder to the Company. This Note and the Loans shall be registered debt obligations for US federal income tax purposes.
The Company will keep, at its principal executive office, books for the registration and registration of transfer of this Note and the
Loans.
(f) For
U.S. federal income tax purposes, parties intend to treat the Note, together with the Warrants, as an investment unit, and the portion
of price deemed paid for the Warrants as resulting in a corresponding reduction in the “issue price” of the applicable Loan
for U.S. federal income tax purposes.
(g) If
any provision of this Note is deemed to be invalid by reason of the operation of law, or by reason of the interpretation placed thereon
by any administrative agency or any court, the Company and Holder shall negotiate an equitable adjustment in the provisions of the same
in order to effect, to the maximum extent permitted by law, the purpose of this and the validity and enforceability of the remaining provisions,
or portions or applications thereof, shall not be affected thereby and shall remain in full force and effect.
[Signature Page Follows]
IN
WITNESS WHEREOF, the Company has executed and delivered Unsecured Promissory Note as of the day and year first written above.
|
P3
Health Group, LLC |
|
|
|
By: |
/s/ Erin Darakjian |
|
Name: |
Erin Darakjian |
|
Its: |
Chief Accounting Officer |
|
Acknowledged and agreed: |
|
VBC
Growth SPV LLC |
|
By: Chicago Pacific Founders GP, L.P., its Manager |
By: Chicago Pacific Founders UGP, LLC, its General Partner |
|
By: |
/s/ Lawrence B. Leisure
|
|
Name: Lawrence B. Leisure |
Title: Manager |
Exhibit 10.2
THE SECURITIES REPRESENTED BY THIS WARRANT HAVE
NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND HAVE BEEN ACQUIRED FOR
INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH SALE OR DISTRIBUTION MAY BE EFFECTED
WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR, SUBJECT TO CERTAIN EXCEPTIONS SPECIFIED HEREIN, AN OPINION OF COUNSEL
IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT.
Warrant No. 1 | Date
of Issuance: December 13, 2022 |
P3 Health
Group, LLC
Class A Common Stock Purchase Warrant
P3 Health Group, LLC (the
“Company”), for value received, hereby certifies that VBC Growth SPV, LLC, or its registered assigns (the “Registered
Holder”), is entitled, subject to the terms set forth below, to purchase from the Company, at any time after the date hereof
and on or before the Expiration Date (as defined in Section 6 below) Class A Common Stock, par value $0.0001 per share (“Shares”)
of P3 Health Partners Inc. (“Parent” at an exercise price per Share equal to $4.26 (as adjusted for subdivisions, combinations,
distributions, recapitalizations and like transactions with respect to the Shares). The Shares issuable upon exercise of this Class A
Common Stock Purchase Warrant (this “Warrant”) and the exercise price per Share, as adjusted from time to time pursuant
to the provisions of this Warrant, are hereinafter referred to as the “Warrant Shares” and the “Exercise Price,”
respectively.
This Warrant is issued pursuant
to, and is subject to the terms and conditions of, that certain Unsecured Promissory Note, among the Company and Registered Holder, dated
as of December 13, 2022, as may be amended from time to time (the “Loan Agreement”).
1. Number
of Shares. Subject to the terms and conditions hereinafter set forth, the Registered Holder is entitled, upon surrender of this
Warrant, to purchase from the Company up to 429,180 Shares.
2. Exercise.
(a) Manner
of Exercise. This Warrant may be exercised by the Registered Holder, in whole or in part, by surrendering this Warrant, with the
purchase/exercise form appended hereto as Exhibit A duly executed by such Registered Holder or by such Registered Holder’s
duly authorized attorney, at the principal office of the Company, or at such other office or agency as the Company may designate, accompanied
by payment in full of the aggregate Exercise Price payable in respect of the number of Warrant Shares purchased upon such exercise (the
“Purchase Price”). The Purchase Price may be paid by cash, check or wire transfer to the Registered Holder.
(b) Effective
Time of Exercise. Each exercise of this Warrant shall be deemed to have been effected immediately prior to the close of business
on the day on which this Warrant shall have been surrendered to the Company as provided in Section 2(a) above. At such time,
the person or persons in whose name or names any certificates for Warrant Shares shall be issuable upon such exercise as provided in Section 2(d) below
shall be deemed to have become the holder or holders of record of the Warrant Shares to be represented by such certificates.
(c) Net
Issue Exercise.
(i) In
lieu of exercising this Warrant in the manner provided above in Section 2(a), the Registered Holder may elect to receive Shares equal
to the value of this Warrant (or the portion thereof being canceled) by surrender of this Warrant at the principal office of the Company
together with notice of such election on the purchase/exercise form appended hereto as Exhibit A duly executed by such Registered
Holder or such Registered Holder’s duly authorized attorney, in which event the Parent shall issue to such Registered Holder a number
of Warrant Shares computed using the following formula:
Where X
= The number of Warrant Shares to be issued to the Registered Holder.
Y = The number
of Warrant Shares purchasable under this Warrant (at the date of such calculation).
A = the VWAP on
the Trading Day immediately preceding the date of such election;
B = The Exercise Price (as adjusted to the date
of such calculation).
(d) (ii) The
“VWAP” means, for any date, the price determined by the first of the following clauses that applies: (i) if the Shares
are then listed on The Nasdaq Global Select Market, The Nasdaq Global Market, The Nasdaq Capital Market or the New York Stock Exchange
(such market, the “Trading Market”), the daily volume-weighted average price of the Shares for such date (or the nearest preceding
date) on the Trading Market as reported by Bloomberg Financial L.P. (based on a “Trading Day” from 9:30 a.m. Eastern
Time to 4:02 p.m. Eastern Time); (ii) the volume-weighted average price of the Shares for such date (or the nearest preceding
date) on the OTC Bulletin Board; (iii) if the Shares are not then listed on a Trading Market or quoted on the OTC Bulletin Board
and if prices for the Shares are then reported in the “Pink Sheets” published by the Pink Sheets, LLC (or a similar organization
or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Shares so reported; or (iv) in
all other cases, the fair market value of a share of Common Stock as determined by a good faith determination of the Parent’s Board
of Directors.
(e) Delivery
to Registered Holder. As soon as practicable after the exercise of this Warrant in whole or in part, and in any event within ten
days thereafter, the Company at its expense will cause to be issued in the name of, and delivered to, the Registered Holder, or as such
Holder (upon payment by such Registered Holder of any applicable transfer taxes) may direct:
(i) a
certificate or certificates for the number of Warrant Shares to which such Registered Holder shall be entitled, and
(ii) in
case such exercise is in part only, a new warrant or warrants (dated the date hereof) of like tenor and with the same date, calling in
the aggregate on the face or faces thereof for the number of Warrant Shares equal (without giving effect to any adjustment thereof) to
the number of such Shares called for on the face of this Warrant minus the number of such Shares purchased by the Registered Holder upon
such exercise as provided in Section 2(a) or 2(c) above (without giving effect to any adjustment thereof).
(f) Limitation
on Exercise. Notwithstanding anything to the contrary herein, Shares may not be issued pursuant to this Warrant and this Warrant
shall not be exercisable for Shares, to the extent that the issuance of the Warrant or the issuance of Shares upon exercise thereof would
constitute, in the good faith determination of the Parent, “ equity compensation” by the Parent pursuant to Nasdaq Listing
Rule 5635(c) or would otherwise be impermissible without shareholder approval pursuant to the Nasdaq Listing Rules. The limitations
contained in this paragraph shall apply to a successor holder of this Warrant.
3. Adjustments.
(a) Subdivision
and Dividends. If outstanding Shares shall be subdivided into a greater number of Shares or a dividend in Shares shall be paid
in respect of Shares, the Exercise Price in effect immediately prior to such subdivision or at the record date of such dividend shall
simultaneously with the effectiveness of such subdivision or immediately after the record date of such dividend be proportionately reduced.
If outstanding Shares shall be combined into a smaller number of Shares, the Exercise Price in effect immediately prior to such combination
shall, simultaneously with the effectiveness of such combination, be proportionately increased. When any adjustment is required to be
made in the Exercise Price, the number of Warrant Shares purchasable upon the exercise of this Warrant shall be changed to the number
determined by dividing (i) an amount equal to the number of Shares issuable upon the exercise of this Warrant immediately prior to
such adjustment, multiplied by the Exercise Price in effect immediately prior to such adjustment, by (ii) the Exercise Price in effect
immediately after such adjustment.
(b) Reclassification,
Etc. In case there occurs any reclassification or change of the outstanding securities of the Parent (or any other
corporation the stock or securities of which are at the time receivable upon the exercise of this Warrant) or any similar corporate
reorganization on or after the date hereof, then and in each such case the Registered Holder, upon the exercise hereof at any time
after the consummation of such reclassification, change, or reorganization, shall be entitled to receive, in lieu of the membership
interests or other securities and property receivable upon the exercise hereof prior to such consummation, the stock or other
securities or property to which such Registered Holder would have been entitled upon such consummation if such Registered Holder had
exercised this Warrant immediately prior thereto, all subject to further adjustment pursuant to the provisions of this
Section 3.
(c) Other
Action Affecting Shares. In case at any time or from time to time the Parent shall take any action of the type contemplated in
Section 3(a) or Section 3(b) hereof but not expressly provided for by such provisions, then, unless in the opinion
of the Parent’s Board of Directors such action will not have an adverse effect upon the rights of the Registered Holder (taking
into consideration, if necessary, any prior actions which the Parent’s Board of Directors deemed not to materially adversely affect
the rights of the Registered Holder), the number of Warrant Shares purchasable upon the exercise of this Warrant shall be adjusted in
such manner and at such time as the Parent’s Board of Directors may in good faith determine to be equitable in the circumstances.
(d) Adjustment
Certificate. When any adjustment is required to be made in the Warrant Shares or the Exercise Price pursuant to this Section 3,
the Company shall promptly mail to the Registered Holder a certificate setting forth (i) a brief statement of the facts requiring
such adjustment, (ii) the Exercise Price after such adjustment and (iii) the kind and amount of stock or other securities or
property into which this Warrant shall be exercisable after such adjustment.
4. No
Avoidance. The Parent
will not, by amendment of its charter, the LLC Agreement or through any reorganization, recapitalization, transfer of assets, consolidation,
merger, share exchange, dissolution or any other voluntary action, avoid or seek to avoid the observance or performance of any of the
terms of this Warrant, including without limitation, the adjustments required under Section 3 hereof. Without limiting the generality
of the foregoing and notwithstanding any other provision of this Warrant to the contrary (including by way of implication), the Parent
will take all such action as may be necessary or appropriate so that the Parent may validly and legally issue Shares upon the exercise
of this Warrant.
5. Transfers.
(a) Unregistered
Security. Each holder of this Warrant acknowledges that this Warrant and the Warrant Shares have not been registered under the
Securities Act, and agrees not to sell, pledge, distribute, offer for sale, transfer or otherwise dispose of this Warrant or any Warrant
Share issued upon its exercise in the absence of (i) an effective registration statement under the Securities Act as to this Warrant
or such Warrant Shares and registration of this Warrant or such Warrant Shares under any applicable U.S. federal or state securities law
then in effect, or (ii) an opinion of counsel, reasonably satisfactory to the Company, that such registration not required under
the Securities Act. Each certificate or other instrument for Warrant Shares issued upon the exercise of this Warrant shall bear a legend
substantially to the foregoing effect. Notwithstanding the transfer restrictions set forth in the preceding sentences of this Section 5(a),
the Registered Holder may assign this Warrant or any Warrant Shares issued upon its exercise or any or all of its rights and interests
hereunder or thereunder, in the absence of registration or qualification of such securities and any opinion of counsel as contemplated
in clauses (i) and (ii) above, to one or more of its affiliates, provided that such transferee shall agree to be bound
by the terms and conditions of this Warrant as a Registered Holder hereunder.
(b) Transferability.
Subject to the provisions of Sections 5(a) and 8(f) hereof, this Warrant and all rights hereunder are transferable, in whole
or in part, upon surrender of the Warrant with a properly executed assignment (in the form of Exhibit B hereto) at the principal
office of the Company.
(c) Warrant
Register. The Company will maintain a register containing the names and addresses of the Registered Holders of this Warrant. Until
any transfer of this Warrant is made in the warrant register, the Company may treat the Registered Holder of this Warrant as the absolute
owner hereof for all purposes; provided, however, that if this Warrant is properly assigned in blank, the Company may (but
shall not be required to) treat the bearer hereof as the absolute owner hereof for all purposes, notwithstanding any notice to the contrary.
Any Registered Holder may change such Registered Holder’s address as shown on the warrant register by written notice to the Company
requesting such change.
6. Termination. This
Warrant (and the right to purchase securities upon exercise hereof) shall terminate upon the earliest to occur of the following (the
“Expiration Date”): (a) December 13, 2027; and (b) the consummation of (i) a sale,
conveyance, disposal, or encumbrance of all or substantially all of the Parent or the Company’s property or business or the
Parent or the Company’s merger into or consolidation with any other corporation (other than a wholly owned subsidiary
corporation) or (ii) any other transaction or series of related transactions in which more than fifty percent (50%) of the
voting power of the Parent or the Company is disposed of. Notwithstanding anything to the contrary herein, if (1) the
Registered Holder has not exercised this Warrant in full prior to the Expiration Date and (2) the fair market value of one
Warrant Share on the Expiration Date exceeds the Exercise Price, this Warrant shall be deemed to be exercised by the Registered
Holder pursuant to Section 2(c) above immediately prior to termination of this Warrant on the Expiration Date.
7. Notices
of Certain Transactions. In case:
(a) the
Parent shall set a record date for all holders of its Shares (or other stock or securities at the time deliverable upon the exercise of
this Warrant) for the purpose of entitling or enabling them to receive any dividend or other distribution, or to receive any right to
subscribe for or purchase any shares of stock of any class or any other securities, or to receive any other right;
(b) of
any capital reorganization of the Parent, any reclassification of the membership interest of the Parent, any consolidation or merger of
the Parent with or into another corporation (other than a consolidation or merger in which the Parent is the surviving entity), or any
transfer of all or substantially all of the assets of the Parent; or
(c) of
the voluntary or involuntary dissolution, liquidation or winding-up of the Parent, then, and in each such case, the Parent will mail
or cause to be mailed to the Registered Holder of this Warrant a notice specifying, as the case may be, (i) the record date for
the purpose of such dividend, distribution or right, and stating the amount and character of such dividend, distribution or right,
or (ii) the effective date on which such reorganization, reclassification, consolidation, merger, transfer, dissolution,
liquidation, winding-up, redemption or offering is to take place, and the time, if any is to be fixed, as of which the holders of
record of Shares (or such other stock or securities at the time deliverable upon such reorganization, reclassification,
consolidation, merger, transfer, dissolution, liquidation, winding-up, redemption or offering) are to be determined. Such notice
shall be mailed at least ten days prior to the record date or effective date for the event specified in such notice.
8. Representations
and Warranties of Registered Holder. The Registered Holder represents and warrants to the Company as follows:
(a) Purchase
for Own Account. This Warrant and the Warrant Shares (collectively, the “Securities”) to be acquired by the Registered
Holder will be acquired for investment for the Registered Holder’s account, not as a nominee or agent, and not with a view to the
public resale or distribution within the meaning of the Securities Act and the Registered Holder has no present intention of selling or
engaging in any public distribution of the same. The Registered Holder also represents that the Registered Holder has not been formed
for the specific purpose of acquiring the Securities.
(b) Disclosure
of Information. The Registered Holder has received or has had full access to all the information it considers necessary or appropriate
to make an informed investment decision with respect to the acquisition of the Securities. The Registered Holder further has had an opportunity
to ask questions and receive answers from the Company and the Parent regarding the terms and conditions of the offering of the Securities
and to obtain additional information (to the extent the Company or the Parent possessed such information or could acquire it without unreasonable
effort or expense) necessary to verify any information furnished to the Registered Holder or to which the Registered Holder has access.
(c) Investment
Experience. The Registered Holder understands that the purchase of the Securities involves substantial risk. The Registered Holder
has experience as an investor in securities of companies in the development stage and acknowledges that the Registered Holder can bear
the economic risk of the Registered Holder’s investment in the Securities and has such knowledge and experience in financial or
business matters that the Registered Holder is capable of evaluating the merits and risks of its investment in the Securities and/or has
a preexisting personal or business relationship with the Company or the Parent and certain of its officers, directors or controlling persons
of a nature and duration that enables the Registered Holder to be aware of the character, business acumen and financial circumstances
of such persons.
(d) Accredited
Investor Status. The Registered Holder is an “accredited investor” within the meaning of Regulation D promulgated under
the Securities Act.
(e) The
Securities Act. The Registered Holder understands that the Securities have not been registered under the Securities Act and are
being issued in reliance upon a specific exemption therefrom, which exemption depends upon, among other things, the bona fide nature
of the Registered Holder’s investment intent as expressed herein. The Registered Holder understands that this the Securities
must be held indefinitely unless subsequently registered under the Securities Act and qualified under applicable state
securities laws, or unless exemption from such registration and qualification are otherwise available. The Registered Holder
acknowledges that the Company has no obligation to register or qualify the Securities for resale.
(f) No
Public Market. The Registered Holder understands that no public market now exists for any of the securities issued by the Company,
and that the Company has made no assurances that a public market will ever exist for the Warrant, and that neither the Company nor the
Parent has made any assurance that a public market will continue to exist for the Warrant Shares.
9. Legends.
The Warrant Shares issued upon exercise of this Warrant shall be imprinted with a legend in substantially the following form (together
with any other legends required by applicable law or the Parent’s Certificate of Incorporation):
THE SECURITIES REPRESENTED BY THIS CERTIFICATE
HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND HAVE BEEN ACQUIRED
FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH SALE OR DISTRIBUTION MAY BE
EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR, SUBJECT TO CERTAIN EXCEPTIONS SPECIFIED HEREIN, AN OPINION OF
COUNSEL IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT.
10. Reservation
of Shares. The Parent will at all times reserve and keep available, solely for the issuance and delivery upon the exercise of
this Warrant, such Warrant Shares and other membership interests, securities and property, as from time to time shall be issuable upon
the exercise of this Warrant.
11. Parent
Guarantee. Parent irrevocably and unconditionally guarantees the Company’s obligations to deliver the Shares as contemplated
under this Warrant.
12. Exchange
of Warrants. Upon the surrender by the Registered Holder of any Warrant or Warrants, properly endorsed, to the Company at the
principal office of the Company, the Company will, subject to the provisions of Section 5 hereof, issue and deliver to or upon the
order of such Registered Holder, at the Company’s expense, a new Warrant or Warrants of like tenor, in the name of such Registered
Holder or as such Registered Holder (upon payment by such Registered Holder of any applicable transfer taxes) may direct, calling in the
aggregate on the face or faces thereof for the number of Shares called for on the face or faces of the Warrant or Warrants so surrendered.
13. Replacement
of Warrants. Upon receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of
this Warrant and (in the case of loss, theft or destruction) upon delivery of an indemnity agreement (with surety if reasonably required)
in an amount reasonably satisfactory to the Company, or (in the case of mutilation) upon surrender and cancellation of this Warrant, the
Company will issue, in lieu thereof, a new Warrant of like tenor.
14. No
Rights as Stockholder. Until the exercise of this Warrant, the Registered Holder of this Warrant shall not have or exercise any
rights by virtue hereof as a stockholder of the Parent.
15. No
Fractional Shares. No fractional Shares will be issued in connection with any exercise hereunder. In lieu of any fractional Shares
which would otherwise be issuable, the Parent shall, at the Parent’s option, round up to the next whole Share, or pay cash equal
to the product of such fraction multiplied by the fair market value of one Share on the date of exercise, as determined in good faith
by the Parent’s Board of Directors.
16. Amendment
or Waiver. Any term of this Warrant may be amended or waived upon written consent of the Company and the holders of at least 50%
of the Shares issuable upon exercise of outstanding warrants issued pursuant to the Loan Agreement. By acceptance hereof, the Registered
Holder acknowledges that in the event the required consent is obtained, any term of this Warrant may be amended or waived with or without
the consent of the Registered Holder.
17. Headings.
The headings in this Warrant are used for convenience only and are not to be considered in construing or interpreting any provision
of this Warrant.
18. Governing
Law. This Warrant shall be governed, construed and interpreted in accordance with the laws of the State of Delaware, without giving
effect to principles of conflicts of law.
19. Successors
and Assigns. Unless otherwise provided in this Warrant, the terms and conditions of this Warrant shall inure to the benefit of
and be binding upon the permitted successors and assigns of the parties. Nothing in this Warrant, express or implied, is intended to confer
upon any party other than the parties hereto or their respective successors and assigns any rights, remedies, obligations, or liabilities
under or by reason of this Warrant, except as expressly provided in this Warrant.
20. Counterparts.
This Warrant may be executed in two or more counterparts, each of which shall be deemed an original and all of which together shall
constitute one instrument.
21. Severability.
If one or more provisions of this Warrant are held to be unenforceable under applicable law, such provision shall be excluded from
this Warrant, the balance of this Warrant shall be interpreted as if such provision were so excluded and shall be enforceable in accordance
with its terms.
22. Delays
or Omissions. No delay or omission to exercise any right, power or remedy accruing to any party under this Warrant, upon any breach
or default of any other party under this Warrant, shall impair any such right, power or remedy of such non-breaching or non-defaulting
party nor shall it be construed to be a waiver of any such breach or default, or an acquiescence therein, or of or in any similar breach
or default thereafter occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default
theretofore or thereafter occurring. Any waiver, permit, consent or approval of any kind or character on the part of any party of any
breach or default under this Warrant, or any waiver on the part of any party of any provisions or conditions of this Warrant, must be
in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Warrant or
by law or otherwise afforded to any party, shall be cumulative and not alternative.
23. Notices.
Unless otherwise provided herein, any notice required or permitted by this Warrant shall be in writing and shall be deemed sufficient
upon delivery, when delivered personally or by overnight courier or sent by facsimile, or 48 hours after being deposited in the U.S. mail,
as certified or registered mail, with postage prepaid, addressed to the party to be notified at such party’s address as set forth
on the signature page, or as subsequently modified by written notice.
[Signature Pages Follow]
The parties have executed
this Class A Common Stock Purchase Warrant as of the date first written above.
|
COMPANY: |
|
|
|
P3 HEALTH GROUP, LLC |
|
|
|
By: |
/s/ Erin Darakjian |
|
Name: Erin Darakjian |
|
Title: Chief Accounting Officer |
|
Address: 2370 Corporate Circle, Suite 300,
Henderson, NV 89074 |
|
|
|
PARENT: |
|
|
|
P3 HEALTH PARTNERS INC. |
|
|
|
By: |
/s/ Erin Darakjian |
|
Name: Erin Darakjian |
|
Title: Chief Accounting Officer |
|
Address: 2370 Corporate Circle, Suite 300,
Henderson, NV 89074 |
|
AGREED TO AND ACCEPTED: |
|
|
|
REGISTERED HOLDER: |
|
|
|
VBC GROWTH SPV LLC |
|
|
|
By: Chicago Pacific Founders GP, L.P., its Manager |
|
By: Chicago Pacific Founders UGP, LLC, its General Partner |
|
|
|
By: |
/s/ Lawrence B. Leisure |
|
Name: Lawrence B. Leisure |
|
Title: Manager |
EXHIBIT A
PURCHASE/EXERCISE FORM
To: P3
Health Group, LLC Dated: [__]
The undersigned, pursuant
to the provisions set forth in the attached Warrant No. [__], hereby irrevocably elects to (choose one):
| ¨ | (a) purchase _____ Shares covered by such Warrant and herewith makes payment of $__________, representing
the full purchase price for such Shares at the price per Share provided for in such Warrant, or |
| ¨ | (b) exercise such Warrant for _______ Shares purchasable under the Warrant pursuant to the Net Issue
Exercise provisions of Section 2(c) of such Warrant. |
The undersigned acknowledges
that it has reviewed the representations and warranties contained in Section 8 of the Warrant and by its signature below hereby makes
such representations and warranties to the Company. Defined terms contained in such representations and warranties shall have the meanings
assigned to them in the Warrant, provided that the term “Registered Holder” shall refer to the undersigned.
|
Signature: |
|
|
|
|
Name (print): |
|
|
|
|
Title (if applicable): |
|
|
|
|
Company (if applicable): |
|
EXHIBIT B
ASSIGNMENT FORM
FOR VALUE RECEIVED, ________________________________________
hereby sells, assigns and transfers all of the rights of the undersigned under the attached Warrant with respect to the number of Shares
covered thereby set forth below, unto:
Name of Assignee |
|
Address/Facsimile Number |
|
No. of Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dated: |
|
|
Signature: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Witness: |
|
Exhibit 10.3
SUBORDINATION AGREEMENT
This Subordination Agreement
(this “Agreement”) is made as of December 13, 2022 among CRG Servicing LLC, a Delaware limited liability
company (“Senior Agent”), and VBC Growth SPV LLC, a Delaware limited liability company (“Subordinated
Creditor”).
RECITALS:
A. P3
Health Group, LLC, a Delaware limited liability company (“Borrower”), intends to issue in favor of Subordinated
Creditor the Subordinated Note (as defined below).
B. Senior
Creditors, Borrower and certain of its subsidiaries have entered into the Senior Loan Agreement (as defined below), and Senior Agent,
Borrower and certain of its subsidiaries have entered into the Senior Security Agreement (as defined below) under which Borrower and such
subsidiaries have granted a security interest in the Collateral (as defined below) in favor of the Senior Creditors as security for the
payment of Borrower’s obligations under the Senior Loan Agreement.
C. To
induce the Lenders under and as defined in the Senior Loan Agreement referred to below to make and maintain the credit extensions to Borrower
and to consent to the issuance of the Subordinated Note, in each case, under the Senior Loan Agreement, Subordinated Creditor is willing
to subordinate the Subordinated Debt (as defined below) to the Senior Debt (as defined below) on the terms and conditions herein set forth.
NOW, THEREFORE, THE PARTIES
AGREE AS FOLLOWS:
1. Definitions.
As used herein, the following terms have the following meanings:
“Bankruptcy Code”
means title 11 of the United States Code, 11 U.S.C. §§ 101 et seq.
“Collateral”
has the meaning set forth in the Senior Security Agreement.
“Enforcement Action”
means, with respect to any indebtedness, obligation (contingent or otherwise) or Collateral at any time held by any lender or noteholder,
(i) commencing, by judicial or non-judicial means, the enforcement of, or otherwise attempting to enforce, such indebtedness, obligation
or Collateral of any of the default remedies under any of the applicable agreements or documents of such lender or noteholder, the UCC
or other applicable law (other than the mere issuance of a notice of default or notice of the right by such lender or noteholder to seek
specific performance with respect to any covenants in favor of such lender or noteholder), (ii) repossessing, selling, leasing or
otherwise disposing of all or any part of such Collateral, including without limitation causing any attachment of, levy upon, execution
against, foreclosure upon or the taking of other action against or institution of other proceedings with respect to any Collateral, or
exercising account debtor or obligor notification or collection rights with respect to all or any portion thereof, or attempting or agreeing
to do so, (iii) appropriating, setting off or applying to such lender or noteholder’s claim any part or all of such Collateral
or other property in the possession of, or coming into the possession of, such lender or noteholder or its agent, trustee or bailee, (iv) asserting
any claim or interest in any insurance with respect to such indebtedness, obligation or Collateral, (v) instituting or commencing,
or joining with any Person in commencing, any action or proceeding with respect to any of the foregoing rights or remedies (including
any action of foreclosure, enforcement, collection or execution and any Insolvency Event involving any Obligor), (vi) exercising
any rights under any lockbox agreement, account control agreement, landlord waiver or bailee’s letter or similar agreement or arrangement
to which the Subordinated Creditor is a party, or (vii) otherwise enforcing, or attempting to enforce, any other rights or remedies
under or with respect to any such indebtedness, obligation or Collateral.
“Insolvency Event”
means that any Obligor or any of its subsidiaries shall have (i) applied for, consented to or acquiesced in the appointment of a
trustee, receiver or other custodian for it or any of its property, or (ii) made a general assignment for the benefit of creditors
or similar arrangement in respect of such Obligor’s or subsidiary’s creditors generally or any substantial portion thereof,
or (iii) permitted, consented to, or suffered to exist the appointment of a trustee, receiver or other custodian for it or for a
substantial part of its property, or (iv) commenced any case, action or proceeding before any court or other governmental agency
or authority relating to bankruptcy, reorganization, insolvency, debt arrangement or relief or other case, action or proceeding under
any bankruptcy or insolvency law, or any dissolution, winding up or liquidation case, action or proceeding, including without limitation
any case under the Bankruptcy Code, in respect of it, or (v) (A) permitted, consented to, or suffered to exist the commencement
of any case, action or proceeding before any court or other governmental agency or authority relating to bankruptcy, reorganization, insolvency,
debt arrangement or relief or other case, action or proceeding under any bankruptcy or insolvency law, or any dissolution, winding up
or liquidation case, action or proceeding, including without limitation any case under the Bankruptcy Code, in respect of it, and (B) any
such case, action or proceeding shall have resulted in the entry of an order for relief or shall have remained for sixty (60) days undismissed.
“Obligor”
has the meaning set forth in the Senior Loan Agreement.
“Person”
has the meaning set forth in the Senior Loan Agreement.
“Senior Creditors”
means Senior Agent and the “Lenders” under and as defined in the Senior Loan Agreement.
“Senior Debt”
means the Obligations (as defined in the Senior Loan Agreement).
“Senior Discharge
Date” means the first date on which all of the Senior Debt (other than contingent indemnification obligations and any Warrant
Obligations (as defined in the Senior Loan Agreement)) has been paid indefeasibly in full in cash and all commitments of Senior Lenders
under the Senior Loan Documents have been terminated.
“Senior Loan Agreement”
means that certain Term Loan Agreement, dated as of November 19, 2020, by and among Borrower, the subsidiary guarantors from time
to time party thereto, and the Senior Creditors, as amended, restated, supplemented or otherwise modified from time to time.
“Senior Loan Documents”
means, collectively, the Loan Documents (as defined in the Senior Loan Agreement), in each case as amended, restated, supplemented or
otherwise modified from time to time.
“Senior Security
Agreement” means that certain Security Agreement, dated as of November 19, 2020, among Borrower, the other Obligors
party thereto, and Senior Agent, as amended, restated, supplemented or otherwise modified from time to time.
“Subordinated
Debt” means and includes all obligations, liabilities and indebtedness of any Obligor owed to Subordinated Creditor, whether
direct or indirect, under the Subordinated Debt Documents.
“Subordinated
Debt Documents” means, collectively, the Subordinated Note and each other loan document or agreement entered into by Borrower
in connection with the Subordinated Note, as amended, restated, supplemented or otherwise modified from time to time.
“Subordinated
Note” means that certain $40,000,000 unsecured promissory note, dated December December 13, 2022, issued by Borrower
to Subordinated Creditor, as amended, restated, supplemented or otherwise modified from time to time.
“UCC”
means the Uniform Commercial Code of any applicable jurisdiction and, if the applicable jurisdiction shall not have any Uniform Commercial
Code, the Uniform Commercial Code as in effect in the State of New York.
2. Liens.
(a) Subordinated Creditor represents and warrants that the Subordinated Debt is unsecured. Subordinated
Creditor agrees that it will not request or accept any security interest in any Collateral to secure the Subordinated Debt; provided
that, should Subordinated Creditor obtain a lien or security interest on any asset or Collateral to secure all or any portion of the
Subordinated Debt for any reason (which action shall be in violation of this Agreement), notwithstanding the respective dates of attachment
and perfection of the security interests in the Collateral in favor of the Senior Creditors or Subordinated Creditor, or any contrary
provision of the UCC, or any applicable law or decision to the contrary, or the provisions of the Senior Loan Documents or the Subordinated
Debt Documents, and irrespective of whether Subordinated Creditor or the Senior Creditors hold possession of any or all part of the Collateral,
all now existing or hereafter arising security interests in the Collateral in favor of Subordinated Creditor in respect of the Subordinated
Debt Documents shall at all times be subordinate to the security interest in such Collateral in favor of the Senior Creditors in respect
of the Senior Loan Documents.
(b) Subordinated
Creditor acknowledges that the Senior Creditors have been granted liens upon the Collateral, and Subordinated Creditor hereby consents
thereto and to the incurrence and maintenance of the Senior Debt.
(c) Until
the Senior Discharge Date, in the event of any private or public sale or other disposition of all or any portion of the Collateral, Subordinated
Creditor agrees that such Collateral shall be sold or otherwise disposed of free and clear of any liens in favor of Subordinated Creditor.
Subordinated Creditor agrees that any such sale or disposition of Collateral shall not require any consent from Subordinated Creditor,
and Subordinated Creditor hereby waives any right it may have to object to such sale or disposition.
(d) Subordinated
Creditor agrees that it will not request or accept any guaranty of the Subordinated Debt.
3. Payment
Subordination. (a) Notwithstanding the terms of the Subordinated Debt Documents, until the Senior Discharge Date, (i) all
payments and distributions of any kind or character, whether in cash, property or securities, in respect of the Subordinated Debt are
subordinated in right and time of payment to all payments in respect of the Senior Debt, and (ii) Subordinated Creditor will not
demand, sue for or receive from Borrower (and Borrower will not pay) any part of the Subordinated Debt, whether by payment, prepayment,
distribution, setoff, or otherwise, or accelerate the Subordinated Debt (provided, that, this clause (a) shall
not prohibit the payment of interest on the Subordinated Debt that is capitalized by adding such amount to the principal balance of the
Subordinated Debt in lieu of being paid in cash).
(b) Subordinated
Creditor must deliver to the Senior Agent in the form received (except for endorsement or assignment by Subordinated Creditor) any payment,
distribution, security or proceeds it receives on the Subordinated Debt other than according to this Agreement.
4. Subordination
of Remedies. Until the Senior Discharge Date, and whether or not any Insolvency Event has occurred, Subordinated Creditor will
not accelerate the maturity of all or any portion of the Subordinated Debt, enforce, attempt to enforce, or exercise any right or remedy
with respect to any Collateral or the Subordinated Debt, or take any other Enforcement Action with respect to the Subordinated Debt.
5. Payments
Over. All payments and distributions of any kind, whether in cash, property or securities, in respect of the Subordinated Debt
to which Subordinated Creditor would be entitled if the Subordinated Debt were not subordinated pursuant to this Agreement, shall be paid
to the Senior Creditors in respect of the Senior Debt, regardless of whether such Senior Debt, or any portion thereof, is reduced, expunged,
disallowed, subordinated or recharacterized. Notwithstanding the foregoing, if any payment or distribution of any kind, whether in cash,
property or securities, shall be received by Subordinated Creditor on account of the Subordinated Debt before Senior Discharge Date (whether
or not expressly characterized as such), then such payment or distribution shall be segregated by Subordinated Creditor and held in trust
for, and shall be promptly paid over to, the Senior Creditors in the same form as received, with any necessary endorsements or as a court
of competent jurisdiction may otherwise direct, in respect of the Senior Debt, regardless of whether such Senior Debt, or any portion
thereof, is reduced, expunged, disallowed, subordinated or recharacterized. Until the Senior Discharge Date, Subordinated Creditor irrevocably
appoints the Senior Agent as Subordinated Creditor’s attorney-in-fact, and grants to the Senior Creditors a power of attorney with
full power of substitution (which power of attorney is coupled with an interest), in the name of Subordinated Creditor or in the name
of the Senior Agent, for the use and benefit of the Senior Creditors, upon notice to Subordinated Creditor, for the sole purpose of making
any such endorsements under this Section 5, if any. This Section 5 shall be enforceable even if the Senior Creditors’
liens on the Collateral are alleged, determined, or held to constitute preferential transfers, or otherwise avoided or voidable, set aside,
recharacterized or equitably subordinated.
6. Insolvency
Proceedings. (a) This Agreement is intended to constitute and shall be deemed to constitute a “subordination agreement”
within the meaning of Section 510(a) of the Bankruptcy Code and is intended to be and shall be interpreted to be enforceable
to the maximum extent permitted pursuant to applicable nonbankruptcy law. All references to Borrower or any other Obligor shall include
Borrower or such Obligor as debtor and debtor-in-possession and any receiver or trustee for Borrower or any other Obligor (as the case
may be) in connection with any case under the Bankruptcy Code or in connection with any other Insolvency Event.
(b) Without
limiting the generality of the other provisions of this Agreement, until the Senior Discharge Date, without the express written consent
of the Senior Agent, Subordinated Creditor shall not institute or commence (nor shall it join with or support any third party instituting,
commencing, opposing, objecting or contesting, as the case may be, or otherwise suffer to exist), any Insolvency Event involving Borrower
or any other Obligor.
(c) The
Senior Creditors shall have the right to enforce rights, exercise remedies (including set-off and the right to credit bid its debt) and
make determinations regarding the release, disposition, or restrictions with respect to the Collateral without any consultation with or
consent of Subordinated Creditor.
(d) Subordinated
Creditor will not, and hereby waives any right to bring, join in, or otherwise support or take any action to (i) contest the validity,
legality, enforceability, perfection, priority or avoidability of any of the Senior Debt, any of the Senior Loan Documents or any security
interests and/or liens of the Senior Creditors on or in any property or assets of Borrower or any other Obligor, including without limitation,
the Collateral; (ii) interfere with or in any manner oppose or support any other Person in opposing any foreclosure on or other disposition
of any Collateral by the Senior Creditors in accordance with applicable law, or otherwise to contest, protest, object to or interfere
with the manner in which the Senior Creditors may seek to enforce the Liens on any Collateral; (iii) provide a debtor-in-possession
facility (including on a priming basis) to Borrower or any other Obligor, under Section 362, 363 or 364 of the Bankruptcy Code or
any other applicable law, without the consent, in their sole discretion, of the Senior Creditors; or (iv) exercise any rights against
the Senior Creditors or the Collateral under Section 506(c) of the Bankruptcy Code.
(e) Subordinated
Creditor will not, and hereby waives any right to, oppose, contest, object to, join in, or otherwise support any opposition to or objection
with respect to, (i) any request or motion of the Senior Creditors seeking, pursuant to Section 362(d) of the Bankruptcy
Code or otherwise, the modification, lifting or vacating of the automatic stay of Section 362(a) of the Bankruptcy Code or from
any other stay in connection with any Insolvency Event or seeking adequate protection of the Senior Creditors’ interests in the
Collateral or with respect to the Senior Debt (whether under Sections 362, 363, and/or 364 of the Bankruptcy Code or other applicable
law), and, until Senior Discharge Date, Subordinated Creditor agrees that it shall not seek relief from such automatic stay without the
prior written consent of the Senior Agent; (ii) any debtor-in-possession financing (including on a priming basis) or use of cash
collateral (as defined in Section 363(a) of the Bankruptcy Code or other applicable law) arrangement by Borrower, whether from
the Senior Creditors or any other third party under Section 362, 363 or 364 of the Bankruptcy Code or any other applicable law, if
the Senior Creditors, in their sole discretion, consent to such debtor-in-possession financing or cash collateral arrangement, and Subordinated
Creditor shall not request adequate protection (whether under Sections 362, 363, and/or 364 of the Bankruptcy Code or other applicable
law) or any other relief in connection therewith; (iii) any sale or other disposition of any of the Collateral or any of the assets
of Borrower or any other Obligor (include any such sale free and clear of liens or other claims) under Section 363 of the Bankruptcy
Code or other applicable law if the Senior Creditors, in their sole discretion, consent to such sale or disposition; (vii) the Senior
Creditors’ exercise or enforcement of its right to make an election under Section 1111(b) of the Bankruptcy Code, and
Subordinated Creditor hereby waives any claim it may hereafter have against the Senior Creditors arising out of such election; (viii) the
Senior Creditors’ exercise or enforcement of its right to credit bid any or all of its debt claims against Borrower or any other
Obligor, including, without limitation, the Senior Debt; or (ix) any plan of reorganization or liquidation if the Senior Creditors,
in their sole discretion, consent to, vote in favor of, or otherwise do not oppose such plan of reorganization or liquidation, and, in
furtherance thereof, Subordinated Creditor hereby grants to the Senior Creditors the right to vote Subordinated Creditor’s claim
or claims (as such term is defined in the Bankruptcy Code) arising on account of or in connection with the Subordinated Debt, as Subordinated
Creditor’s agent, with respect to any plan of reorganization or liquidation to which Subordinated Creditor may be entitled to vote
in any bankruptcy or liquidation proceeding or in connection with any other Insolvency Event of Borrower or any other Obligor.
7. Distributions
of Proceeds of Collateral. Until the Senior Discharge Date, all realizations upon any Collateral pursuant to or in connection
with an Enforcement Action, an Insolvency Event or otherwise shall be paid or delivered to the Senior Agent in respect of the Senior Debt
before any payment may be made to Subordinated Creditor.
8. Release
of Liens. In the event of any private or public sale or other disposition, by or with the consent of the Senior Agent, of all
or any portion of the Collateral, Subordinated Creditor agrees that such sale or disposition shall be free and clear of any liens Subordinated
Creditor may have on such Collateral. Subordinated Creditor agrees that, in connection with any such sale or other disposition, (i) the
Senior Creditors are authorized to file any and all UCC and other applicable lien releases and/or terminations in respect of any liens
held by Subordinated Creditor in connection with such a sale or other disposition, and (ii) it shall execute any and all lien releases
or other documents reasonably requested by the Senior Agent in connection therewith. In furtherance of the foregoing, until the Senior
Discharge Date, Subordinated Creditor hereby appoints the Senior Agent as its attorney-in-fact, with full authority in the place and stead
of Subordinated Creditor and full power of substitution and in the name of Subordinated Creditor or otherwise, solely for the purpose
of executing and delivering any document or instrument which Subordinated Creditor is required to deliver pursuant to this Section 8,
such appointment being coupled with an interest and irrevocable. Subordinated Creditor agrees that the Senior Creditors may release or
refrain from enforcing their security interest in any Collateral, or permit the use or consumption of such Collateral by Borrower free
of any Subordinated Creditor security interest, without incurring any liability to Subordinated Creditor.
9. Attorney-In-Fact.
Until the Senior Discharge Date, Subordinated Creditor irrevocably appoints the Senior Agent as its attorney-in-fact, with power of attorney
with power of substitution, in Subordinated Creditor’s name or in any Senior Creditor’s name, for the Senior Creditors’
use and benefit, with notice to Subordinated Creditor, solely for the purpose of doing the following during an Insolvency Event:
(a) file
any claims in respect of the Subordinated Debt on behalf of Subordinated Creditor if Subordinated Creditor does not do so at least 30
days before the time to file claims expires; and
(b) vote
Subordinated Creditor’s claim or claims (as such term is defined in the Bankruptcy Code) arising on account of or in connection
with the Subordinated Debt, as Subordinated Creditor’s agent, with respect to any plan of reorganization or liquidation to which
Subordinated Creditor may be entitled to vote in any bankruptcy or liquidation proceeding or in connection with any other Insolvency Event
of Borrower or any other Obligor.
Such power of attorney is
irrevocable and coupled with an interest.
10. Legend;
Amendment of Debt. (a) Subordinated Creditor will immediately put a legend on or otherwise indicate on the Subordinated
Note that the Subordinated Note is subject to this Agreement.
(b) Until
the Senior Discharge Date, Subordinated Creditor shall not, without prior written consent of the Senior Agent, agree to any amendment,
modification or waiver of any provision of the Subordinated Debt Documents, if the effect of such amendment, modification or waiver is
to: (i) terminate or impair the subordination of the Subordinated Debt in favor of the Senior Creditors; (ii) increase the interest
rate on the Subordinated Debt or change (to earlier dates) the dates upon which principal, interest and other sums are due under the Subordinated
Note; (iii) alter the redemption, prepayment or subordination provisions of the Subordinated Debt; (iv) impose on Borrower or
any other Obligor any new or additional prepayment charges, premiums, reimbursement obligations, reimbursable costs or expenses, fees
or other payment obligations; (v) alter the representations, warranties, covenants, events of default, remedies and other provisions
in a manner which would make such provisions materially more onerous, restrictive or burdensome to Borrower or any other Obligor; (vi) grant
a lien or security interest in favor of any holder of the Subordinated Debt on any asset or Collateral to secure all or any portion of
the Subordinated Debt; or (vii) otherwise increase the obligations, liabilities and indebtedness in respect of the Subordinated Debt
or confer additional rights upon Subordinated Creditor, which individually or in the aggregate would be materially adverse to Borrower,
any other Obligor or the Senior Creditors. Any such amendment, modification or waiver made in violation of this Section 10(b) shall
be void.
(c) At
any time without notice to Subordinated Creditor, the Senior Creditors may take such action with respect to the Senior Debt as the Senior
Creditors, in their sole discretion, may deem appropriate, including, without limitation, terminating advances, increasing the principal,
extending the time of payment, increasing interest rates, renewing, compromising or otherwise amending any documents affecting the Senior
Debt and any Collateral securing the Senior Debt, and enforcing or failing to enforce any rights against Borrower or any other person;
provided, that, notwithstanding the foregoing, the Senior Creditors shall not agree to any amendment, modification or waiver
of any provision of the Senior Debt without Subordinated Creditor’s prior written consent if the effect of such amendment, modification
or waiver is to: (i) increase the principal of the Senior Debt (other than as a result of capitalized interest) or increase the Obligations,
in each case, above $180,000,000, (ii) extend the time of payment of the Senior Debt, or (iii) renew, replace, extend or supplement
the Senior Debt or Obligations other than as permitted by clauses (i) and (ii) above. No action or inaction will
impair or otherwise affect any Senior Creditor’s rights under this Agreement.
11. Certain
Waivers. (a) Subordinated Creditor hereby (i) waives any and all notice of the incurrence of the Senior Debt or
any part thereof; (ii) waives any and all rights it may have to require the Senior Creditors to marshal assets, to exercise rights
or remedies in a particular manner, to forbear from exercising such rights and remedies in any particular manner or order, or to claim
the benefit of any appraisal, valuation or other similar right that may otherwise be available under applicable law, regardless of whether
any action or failure to act by or on behalf of the Senior Creditors is adverse to the interest of Subordinated Creditor; (iii) agrees
that the Senior Creditors shall have no liability to Subordinated Creditor, and Subordinated Creditor hereby waives any claim against
the Senior Creditors arising out of any and all actions not in breach of this Agreement which the Senior Creditors may take or permit
or omit to take with respect to the Senior Loan Documents (including any failure to perfect or obtain perfected security interests in
the Collateral), the collection of the Senior Debt or the foreclosure upon, or sale, liquidation or other disposition of, any Collateral;
and (iv) agrees that the Senior Creditors have no duty, express or implied, fiduciary or otherwise, to them in respect of the maintenance
or preservation of the Collateral, the Senior Debt or otherwise. Without limiting the foregoing, Subordinated Creditor agrees that the
Senior Creditors shall have no duty or obligation to maximize the return to any class of creditors holding indebtedness of any type (whether
Senior Debt or Subordinated Debt), notwithstanding that the order and timing of any realization, sale, disposition or liquidation of the
Collateral may affect the amount of proceeds actually received by such class of creditors from such realization, sale, disposition or
liquidation.
(b) Subordinated
Creditor confirms that this Agreement shall govern as between the Senior Creditors and the Subordinated Creditor irrespective of: (i) any
lack of validity or enforceability of any Senior Loan Document or any Subordinated Debt Document; (ii) the occurrence of any Insolvency
Event in respect of any Obligor; (iii) whether the Senior Debt, or the liens or security interests securing the Senior Debt, shall
be held to be unperfected, deficient, invalid, void, voidable, voided, unenforceable, subordinated, reduced, discharged or are set aside
by a court of competent jurisdiction, including pursuant or in connection with any Insolvency Event; (iv) any change in the time,
manner or place of payment of, or in any other terms of, all or any of the Senior Debt or the Subordinated Debt, or any amendment or waiver
or other modification, including any increase in the amount thereof, whether by course of conduct or otherwise, of the terms of any Senior
Loan Document or any Subordinated Debt Document or any guarantee thereof; or (v) any other circumstances which otherwise might constitute
a defense available to, or a discharge of, any Obligor in respect of the Senior Debt or the Subordinated Debt.
12. Representations
and Warranties. Subordinated Creditor represents and warrants to the Senior Creditors that:
(a) all
action on the part of Subordinated Creditor, its officers, directors, partners, members and shareholders, as applicable, necessary for
the authorization of this Agreement and the performance of all obligations of Subordinated Creditor hereunder has been taken;
(b) this
Agreement constitutes the legal, valid and binding obligation of Subordinated Creditor, enforceable against Subordinated Creditor in accordance
with its terms;
(c) the
execution, delivery and performance of and compliance with this Agreement by Subordinated Creditor will not (i) result in any material
violation or default of any term of any of Subordinated Creditor’s charter, formation or other organizational documents (such as
Articles or Certificate of Incorporation, bylaws, partnership agreement, operating agreement, etc.) or (ii) violate any material
applicable law, rule or regulation; and
(d) Subordinated
Creditor has not previously assigned any interest in the Subordinated Debt, and no Person other than the Subordinated Creditor owns an
interest in the Subordinated Debt.
13. Term;
Reinstatement. This Agreement shall remain in full force and effect until the Senior Discharge Date, notwithstanding the occurrence
of an Insolvency Event. If, after the Senior Discharge Date, the Senior Creditors must disgorge any payments made on the Senior Debt for
any reason (including, without limitation, in connection with the bankruptcy of Borrower or in connection with any other Insolvency Event),
this Agreement and the relative rights and priorities provided in it, will be reinstated as to all disgorged payments as though such payments
had not been made, and Subordinated Creditor will immediately pay the Senior Agent all payments received in respect of the Subordinated
Debt to the extent such payments or retention thereof would have been prohibited under this Agreement.
14. Successors
and Assigns. This Agreement binds Subordinated Creditor, its successors or assigns, and benefits the Senior Creditors’
successors or assigns. This Agreement is for Subordinated Creditor’s and the Senior Creditors’ benefit and not for the benefit
of Borrower or any other party. Subordinated Creditor shall not sell, assign, pledge, dispose of or otherwise transfer all or any portion
of the Subordinated Debt or any related document or any interest in any Collateral therefor unless prior to the consummation of any such
action, the transferee thereof shall execute and deliver to the Senior Agent an agreement of such transferee to be bound hereby, or an
agreement substantially identical to this Agreement providing for the continued subjection of the Subordinated Debt, the interests of
the transferee in the Collateral and the remedies of the transferee with respect thereto as provided herein with respect to Subordinated
Creditor and for the continued effectiveness of all of the other rights of the Senior Creditors arising under this Agreement, in each
case in form satisfactory to the Senior Creditors. Any such sale, assignment, pledge, disposition or transfer not made in compliance with
the terms of this Section 14 shall be void but shall not affect the subordination provisions of this Agreement.
15. Further
Assurances. Subordinated Creditor hereby agrees to execute such documents and/or take such further action as the Senior Agent
may at any time or times reasonably request in order to carry out the provisions and intent of this Agreement, including, without limitation,
ratifications and confirmations of this Agreement from time to time hereafter, as and when requested by the Senior Agent.
16. Counterparts.
This Agreement may be executed in two or more counterparts, each of which shall be deemed an original and all of which together shall
constitute one instrument. Executed counterparts may be delivered by facsimile or email.
17. Governing
Law; Waiver of Jury Trial. (a) This Agreement and the rights and obligations of the parties hereunder shall be governed
by, and construed in accordance with, the law of the State of New York, without regard to principles of conflicts of laws that would result
in the application of the laws of any other jurisdiction; provided that Section 5-1401 of the New York General Obligations
Law shall apply.
(b) EACH
PARTY HERETO WAIVES ITS RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS AGREEMENT OR ANY OF THE
TRANSACTIONS CONTEMPLATED HEREIN.
18. Entire
Agreement; Waivers and Amendments. This Agreement represents the entire agreement with respect to the subject matter hereof,
and supersedes all prior negotiations, agreements and commitments. The Senior Creditors and Subordinated Creditor are not relying on any
representations by the other creditor party or Borrower in entering into this Agreement, and each of the Senior Creditors and Subordinated
Creditor has kept and will continue to keep itself fully apprised of the financial and other condition of Borrower. No amendment, modification,
supplement, termination, consent or waiver of or to any provision of this Agreement, nor any consent to any departure therefrom, shall
in any event be effective unless the same shall be in writing and signed by the Senior Agent and Subordinated Creditor. Any waiver of
any provision of this Agreement, or any consent to any departure from the terms of any provision of this Agreement, shall be effective
only in the specific instance and for the specific purpose for which given.
19. No
Waiver. No failure or delay on the part of any Senior Creditor or Subordinated Creditor in the exercise of any power, right,
remedy or privilege under this Agreement shall impair such power, right, remedy or privilege or shall operate as a waiver thereof, nor
shall any single or partial exercise of any such power, right or privilege preclude any other or further exercise of any other power,
right or privilege. The rights and remedies under this Agreement are cumulative and not exclusive of any rights, remedies, powers and
privileges that may otherwise be available to any Senior Creditor.
20. Legal
Fees. In the event of any legal action to enforce the rights of a party under this Agreement, the party prevailing in such
action shall be entitled, in addition to such other relief as may be granted, all reasonable, invoiced and out-of-pocket costs and expenses,
including reasonable attorneys’ fees, incurred in such action.
21. Severability.
Any provision of this Agreement which is illegal, invalid, prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction,
be ineffective to the extent such illegality, invalidity, prohibition or unenforceability without invalidating or impairing the remaining
provisions hereof or affecting the validity or enforceability of such provision in any other jurisdiction.
22. Notices.
All notices, demands, instructions and other communications required or permitted to be given to or made upon any party hereto shall be
in writing and shall be delivered or sent by first-class mail, postage prepaid, or by overnight courier or messenger service or by facsimile
or electronic mail, message confirmed, and shall be deemed to be effective for purposes of this Agreement on the day that delivery is
made or refused. Unless otherwise specified in a notice mailed or delivered in accordance with the foregoing sentence, notices, demands,
instructions and other communications in writing shall be given to or made upon the respective parties hereto at their respective addresses
and facsimile numbers or email addresses indicated on the signature pages hereto.
23. No
Third-Party Beneficiaries; Other Benefits. The terms and provisions of this Agreement are intended solely for the benefit of
each party hereto and their respective successors and permitted assigns, and the parties do not intend to confer third party beneficiary
rights upon any other person. Subordinated Creditor understands that there may be various agreements between the Senior Creditors and
Borrower or the other Obligors evidencing and governing the Senior Debt, and Subordinated Creditor acknowledges and agrees that such agreements
are not intended to confer any benefits on Subordinated Creditor and that the Senior Creditors shall have no obligation to Subordinated
Creditor or any other Person to exercise any rights, enforce any remedies, or take any actions which may be available to it under such
agreements.
[Signature pages follow]
IN WITNESS WHEREOF, the undersigned have executed
this Agreement as of the date first above written.
SUBORDINATED CREDITOR:
VBC GROWTH SPV LLC
By: Chicago Pacific Founders GP, L.P., its Manager |
By: Chicago Pacific Founders UGP, LLC, its General Partner |
|
|
By |
/s/ Lawrence B. Leisure |
|
|
Name: Lawrence B. Leisure |
|
|
Title: Manager |
|
Address for Notices:
Chicago Pacific Founders Fund, L.P.
980 N. Michigan Ave., Suite 1998
Chicago, IL 60611
Attn: Greg Kazarian
Tel: 312-213-2141
Email: gkazarian@cpfounders.com
and to:
Locke Lord LLP
111 South Wacker
Chicago, IL 60606
Attn: Michael R. Wilson
Tel.: 312-201-2522
Fax: 855-595-1187
Email: michael.wilson@lockelord.com
|
SENIOR AGENT (on behalf of the SENIOR
CREDITORS): |
|
|
|
CRG SERVICING LLC |
|
|
|
By |
/s/ Nathan Hukill |
|
|
Name: Nathan Hukill |
|
|
Title: Authorized Signatory |
|
|
|
Address for Notices: |
|
1000 Main Street, Suite 2500 |
|
Houston, TX 77002 |
|
Attn: Portfolio Reporting |
|
Tel.: 713.209.7350 |
|
Fax: 713.209.7351 |
|
Email: notices@crglp.com |
|
P3 HEALTH GROUP, LLC |
|
|
|
By: |
/s/
Erin Darakjian |
|
Name: Erin Darakjian |
|
Title: Chief Accounting Officer |
|
|
|
Address for Notices: |
|
2370 Corporate Circle |
|
Suite 300 |
|
Henderson, NV 89074 |
|
Attn: Erin Darakjian, Chief Accounting Officer |
|
Tel.: (702) 780-2543 |
|
Email: edarakjian@p3hp.org |
|
|
|
With a copy (which shall not constitute
notice) to: |
|
|
|
Latham & Watkins LLP |
|
1271 Avenue of the Americas |
|
New York, NY 10020 |
|
Attn: Scott Ollivierre |
|
Tel.: +1.212.906.1397 |
|
Email: Scott.Ollivierre@lw.com |
|
|
Exhibit 10.4
THIRD AMENDMENT TO TERM LOAN AGREEMENT
THIS THIRD AMENDMENT TO TERM
LOAN AGREEMENT (this “Agreement”), dated as of December 13, 2022, is entered into among P3 HEALTH GROUP, LLC,
a Delaware limited liability company (“Borrower”) (formerly known as FAC MERGER SUB LLC, successor by merger
to P3 HEALTH GROUP HOLDINGS, LLC), the Subsidiary Guarantors party hereto, the Lenders party hereto and CRG SERVICING LLC, as administrative
agent and collateral agent (the “Agent”). All capitalized terms used herein and not otherwise defined herein
shall have the meanings given to such terms in the Term Loan Agreement (as defined below).
RECITALS
WHEREAS, the Borrower, the
Subsidiary Guarantors from time to time party thereto, the Lenders from time to time party thereto and the Agent have entered into that
certain Term Loan Agreement, dated as of November 19, 2020 (as amended, restated, supplemented or modified from time to time, the “Term
Loan Agreement”);
WHEREAS, the Obligors have
requested that the Lenders and the Agent amend the Term Loan Agreement to provide for certain modifications of the terms thereof, including
to permit the transactions contemplated by the VBC Note Documents; and
WHEREAS, the Lenders and the
Agent are willing to amend the Term Loan Agreement subject to the terms and conditions hereof.
NOW, THEREFORE, in consideration
of the premises and the mutual covenants contained herein, and for other good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, the parties hereto agree as follows:
1.
Amendments to Term Loan Agreement.
(a)
Section 1.01 of the Term Loan Agreement is hereby amended by adding the following definitions in the appropriate alphabetical order:
“Third
Amendment Effective Date” means December 13, 2022.
“VBC”
means VBC Growth SPV LLC, a Delaware limited liability company.
“VBC Note”
means that certain Unsecured Promissory Note, dated as of the Third Amendment Effective Date, by and between the Borrower and VBC, in
the original principal amount of Forty Million Dollars ($40,000,000), as amended, restated, supplemented or otherwise modified from time
to time in accordance with the terms of the VBC Subordination Agreement.
“VBC Note
Documents” means the VBC Note and all other agreements, instruments and documents executed and delivered in connection with
the VBC Note, in each case as amended or otherwise modified in accordance with the terms of the VBC Subordination Agreement.
“VBC Subordinated
Debt” means the unsecured Indebtedness of Borrower incurred pursuant to the VBC Note Documents.
“VBC Subordination
Agreement” means that certain subordination agreement, dated as of the Third Amendment Effective Date, among VBC, the Administrative
Agent and Borrower.
(b)
The definition of “Change of Control” in Section 1.01 of the Term Loan Agreement is hereby amended by replacing the
text “(d) the occurrence of any “Change of Control” (or any equivalent term) under any documentation governing Material
Indebtedness (other than the Intermountain Subordinated Debt) or (e) the occurrence of any “Change of Control Transaction”
under any Intermountain Note Document.” with the text “(d) the occurrence of any “Change of Control” (or any equivalent
term) under any documentation governing Material Indebtedness (other than the Intermountain Subordinated Debt or the VBC Subordinated
Debt), (e) the occurrence of any “Change of Control Transaction” under any Intermountain Note Document or (f) the occurrence
of any “Change of Control” under any VBC Note Document.”.
(c)
The definition of “Loan Documents” in Section 1.01 of the Term Loan Agreement is hereby amended by adding the text
“the VBC Subordination Agreement,” immediately before the text “the Intermountain Subordination Agreement”.
(d)
The definition of “Material Indebtedness” in Section 1.01 of the Term Loan Agreement is hereby amended by replacing
the text “and (b) the Intermountain Subordinated Debt.” with the text “, (b) the Intermountain Subordinated Debt and
(c) the VBC Subordinated Debt.”.
(e) Section
8.01(j) of the Term Loan Agreement is hereby amended by adding the text “or the holders of the VBC Subordinated Debt” immediately
after the text “the Intermountain Subordinated Debt”.
(f) Section
9.01 of the Term Loan Agreement is hereby amended by (i) replacing the text “; and” at the end of clause (q) thereof with
the text “;”, (ii) replacing the text “.” at the end of clause (s) thereof with the text “; and” and
(iii) adding the following as a new clause (t) thereof to read as follows:
(t) VBC
Subordinated Debt; provided, that, (i) the VBC Subordinated Debt is at all times subject to the terms and conditions of
the VBC Subordination Agreement, (ii) the VBC Subordinated Debt is unsecured, (iii) no Subsidiary shall Guarantee the VBC Subordinated
Debt and (iv) the aggregate principal amount of the VBC Subordinated Debt shall not exceed at any one time outstanding the sum of (A)
Forty Million Dollars ($40,000,000) plus (B) capitalized interest on the VBC Subordinated Debt that is added to the principal balance
thereof in accordance with the terms of the VBC Note (in lieu of being paid in cash).
(g) Section
9.07 of the Term Loan Agreement is hereby amended and restated to read, in its entirety, as follows:
9.07 Payments
of Indebtedness. Such Obligor shall not, and shall not permit any of its Subsidiaries to, make (a) any voluntary or optional
payments in respect of any Indebtedness (other than Intermountain Subordinated Debt and VBC Subordinated Debt) that is subordinated
to the Obligations other than payments thereof that are permitted under the terms of the applicable subordination or intercreditor
agreement to which the Administrative Agent is a party, (b) any payments in respect of Intermountain Subordinated Debt other than
the payments of interest that are capitalized by adding such interest payment amounts to the principal balance of the Intermountain
Subordinated Debt (in lieu of being paid in cash) in accordance with the terms of the Intermountain Note in effect as of the Closing
Date or (c) any payments in respect of VBC Subordinated Debt other than the payments of interest that are capitalized by adding such
interest payment amounts to the principal balance of the VBC Subordinated Debt (in lieu of being paid in cash) in accordance with
the terms of the VBC Note in effect as of the Third Amendment Effective Date.
(h) Section
9.12 of the Term Loan Agreement is hereby amended by replacing the text “or (b) enter into any amendment or modification of any
Intermountain Note Document in a manner adverse to the Secured Parties or in violation of the Intermountain Subordination Agreement.”
with the text “, (b) enter into any amendment or modification of any Intermountain Note Document in a manner adverse to the Secured
Parties or in violation of the Intermountain Subordination Agreement or (c) enter into any amendment or modification of any VBC Note Document
in a manner adverse to the Secured Parties or in violation of the VBC Subordination Agreement.”.
(i) Section
11.01(g) of the Term Loan Agreement is hereby amended by replacing the text “(ii) any “Event of Default” occurs under
any Intermountain Note Document” with the text “(ii) any “Event of Default” occurs under any Intermountain Note
Document or any “Event of Default” occurs under any VBC Note Document”.
(j) Section
12.01(b) of the Term Loan Agreement is hereby amended by replacing the text “(ix) enter into non-disturbance agreements and similar
agreements and (x)” with the text “(ix) enter into the VBC Subordination Agreement, (x) enter into non-disturbance agreements
and similar agreements and (xi)”.
2.
Conditions Precedent. The effectiveness of this Agreement shall be subject to the satisfaction of each of the following
conditions precedent:
(a) receipt
by the Agent of counterparts of (i) this Agreement duly executed by the Obligors, the Majority Lenders and the Agent, (ii) the VBC Subordination
Agreement duly executed by VBC, the Borrower and the Agent and (iii) each VBC Note Document duly executed by the parties thereto; and
(b) the
representation and warranty in Section 5(c) of this Agreement shall be true and correct on the date hereof.
3.
Expenses. The Obligors agree to reimburse the Agent for all reasonable fees, charges and disbursements of the Agent in connection
with the preparation, execution and delivery of this Agreement, including the reasonable fees, charges and disbursements of Moore &
Van Allen PLLC.
4. Reaffirmation.
Each of the Obligors acknowledges and reaffirms (a) that it is bound by all of the terms of the Loan Documents to which it is a party
and (b) that it is responsible for the observance and full performance of all Obligations, including without limitation, the repayment
of the Loans. Furthermore, the Obligors acknowledge and confirm (i) that the Lenders have performed fully all of their obligations under
the Term Loan Agreement and the other Loan Documents arising on or before the date hereof other than their respective obligations specifically
set forth in this Agreement and (ii) that by entering into this Agreement, the Lenders do not, except as expressly set forth herein, waive
or release any term or condition of the Term Loan Agreement or any of the other Loan Documents or any of their rights or remedies under
such Loan Documents or any applicable law or any of the Obligations of the Obligors thereunder.
5. Miscellaneous.
(a) The
Term Loan Agreement and the Obligations of the Obligors thereunder and under the other Loan Documents, are hereby ratified and confirmed
and shall remain in full force and effect according to their terms, as amended by this Agreement. This Agreement is a Loan Document.
(b) Each
Guarantor (i) acknowledges and consents to all of the terms and conditions of this Agreement, (ii) affirms all of its Obligations under
the Loan Documents, and (iii) agrees that this Agreement and all documents executed in connection herewith do not operate to reduce or
discharge its Obligations under the Term Loan Agreement or the other Loan Documents.
(c) The
Obligors represent and warrant to the Agent and the Lenders that:
(i) each
Obligor has taken all necessary corporate, limited liability company or other organizational action to authorize the execution, delivery
and performance of this Agreement;
(ii) this
Agreement has been duly executed and delivered by each Obligor and constitutes a legal, valid and binding obligation of each Obligor,
enforceable against each such Obligor in accordance with its terms, subject to bankruptcy, insolvency and similar laws affecting enforceability
of creditors’ rights generally and to general principles of equity;
(iii) no
approval, consent, exemption, authorization or other action by, or notice to, or filing with, any Governmental Authority or any other
Person is necessary or required in connection with the execution, delivery or performance by, or enforcement against, any Obligor of this
Agreement other than (A) those that have already been obtained and are in full force and effect and (B) those that may be required under
any applicable notices under securities laws; and
(iv) (A)
the representations and warranties of each Obligor contained in Section 7 of the Term Loan Agreement or in any other Loan Document, or
which are contained in any document furnished at any time under or in connection therewith, are true and correct in all material respects
(and in all respects if any such representation and warranty is already qualified by materiality or reference to Material Adverse Change
or Material Adverse Effect) on and as of the date hereof, except to the extent that such representations and warranties specifically refer
to an earlier date, in which case they are true and correct in all material respects (and in all respects if any such representation and
warranty is already qualified by materiality or reference to Material Adverse Change or Material Adverse Effect) as of such earlier date
and (B) no event has occurred and is continuing which constitutes a Default or an Event of Default.
(d) Each of
the Obligors hereby affirms the Liens created and granted in the Loan Documents in favor of the Agent, for the benefit of the Secured
Parties, and agrees that this Agreement does not adversely affect or impair such Liens and security interests in any manner.
(e) This
Agreement may be executed in counterparts (and by different parties hereto in different counterparts), each of which shall
constitute an original, but all of which when taken together shall constitute a single contract. Delivery of an executed counterpart
of a signature page of this Agreement by facsimile or other electronic imaging means (e.g. “pdf” or “tif”)
shall be effective as delivery of a manually executed counterpart of this Agreement.
(f) If
any provision of this Agreement is held to be illegal, invalid or unenforceable, (i) the legality, validity and enforceability of the
remaining provisions of this Agreement shall not be affected or impaired thereby and (ii) the parties shall endeavor in good faith negotiations
to replace the illegal, invalid or unenforceable provisions with valid provisions the economic effect of which comes as close as possible
to that of the illegal, invalid or unenforceable provisions. The invalidity of a provision in a particular jurisdiction shall not invalidate
or render unenforceable such provision in any other jurisdiction.
(g) THIS
AGREEMENT AND ANY CLAIM, CONTROVERSY, DISPUTE OR CAUSE OF ACTION (WHETHER IN CONTRACT OR TORT OR OTHERWISE) BASED UPON, ARISING OUT OF
OR RELATING TO THIS AGREEMENT AND THE TRANSACTIONS CONTEMPLATED HEREBY, SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS
OF THE STATE OF NEW YORK.
[SIGNATURE PAGES FOLLOW]
IN WITNESS WHEREOF, the parties
hereto have caused this Agreement to be duly executed as of the date first above written.
|
|
BORROWER: |
P3 HEALTH GROUP, LLC |
|
|
|
By: |
/s/ Erin Darakjian |
|
Name: Erin Darakjian |
|
Title: Chief Accounting Officer |
SUBSIDIARY GUARANTORS:
P3 HEALTH PARTNERS, LLC |
|
P3 HEALTH GROUP MANAGEMENT, LLC |
|
|
|
By: |
/s/ Erin Darakjian |
|
By: |
/s/ Erin Darakjian |
Name: Erin Darakjian |
|
Name: Erin Darakjian |
Title: Chief Accounting Officer |
|
Title: Chief Accounting Officer |
|
|
|
P3 HEALTH GROUP CONSULTING, LLC |
|
P3 HEALTH PARTNERS-NEVADA, LLC |
|
|
|
By: |
/s/ Erin Darakjian |
|
By: |
/s/ Erin Darakjian |
Name: Erin Darakjian |
|
Name: Erin Darakjian |
Title: Chief Accounting Officer |
|
Title: Chief Accounting Officer |
|
|
|
P3 HEALTH PARTNERS-OREGON, LLC |
|
P3 HEALTH PARTNERS-FLORIDA, LLC |
|
|
|
By: |
/s/ Erin Darakjian |
|
By: |
/s/ Erin Darakjian |
Name: Erin Darakjian |
|
Name: Erin Darakjian |
Title: Chief Accounting Officer |
|
Title: Chief Accounting Officer |
|
|
|
P3 HEALTH PARTNERS ACO, LLC |
|
P3 HEALTH PARTNERS-CALIFORNIA, LLC |
|
|
|
By: |
/s/ Erin Darakjian
|
|
By: |
/s/ Erin Darakjian |
Name: Erin Darakjian |
|
Name: Erin Darakjian |
Title: Chief Accounting Officer |
|
Title: Chief Accounting Officer |
P3 HEALTH GROUP HOLDINGS, LLC
THIRD AMENDMENT
|
By: |
/s/ Nathan Hukill |
|
Name: Nathan Hukill |
|
Title: Authorized Signatory |
LENDERS: |
CRG PARTNERS IV L.P. |
|
By: CRG PARTNERS IV GP L.P., its general partner |
|
|
By: CRG PARTNERS IV GP LLC, its general partner |
|
|
|
|
By: |
/s/ Nathan Hukill |
|
|
Name: Nathan Hukill |
|
|
Title: Authorized Signatory |
|
CRG PARTNERS IV
– PARALLEL FUND “C” (CAYMAN) L.P. |
|
By: CR GROUP L.P.., its investment advisor |
|
|
|
|
By: |
/s/ Nathan Hukill |
|
|
Name: Nathan Hukill |
|
|
Title: Authorized Signatory |
|
CRG PARTNERS IV – CAYMAN LEVERED L.P. |
|
By: CRG PARTNERS IV (CAYMAN) GP L.P., its general partner |
|
|
By: CRG PARTNERS IV GP LLC, its general partner |
|
|
|
|
By: |
/s/ Nathan Hukill |
|
|
Name: Nathan Hukill |
|
|
Title: Authorized Signatory |
P3 HEALTH GROUP HOLDINGS, LLC
THIRD AMENDMENT